Breaking News

ABBV

AbbVie

05
May
21
May

03/16/23 Chardan: Immunome price target lowered to $8 from $9 at Chardan

03/01/23 Guggenheim: Guggenheim starts AbbVie with a Buy on diversified growth

02/28/23 Guggenheim: AbbVie initiated with a Buy at Guggenheim

02/22/23 BMO Capital: AbCellera price target lowered to $32 from $40 at BMO Capital

Clear This Search Refresh Search

Thursday Show Full Stories X To view all stories in expanded form, please subscribe. Get Free Trial Send Info
Hot Stocks	AbbVie advances clinical program of upadacitinib in SLE to Phase 3 » 09:03 03/23/23 03/23 09:03 03/23/23 09:03 ABBV AbbVie $153.67 / -3.155 (-2.01%) AbbVie announced topline… AbbVie announced topline results from a Phase 2 study of upadacitinib given alone or as combination therapy with a Bruton's Tyrosine Kinase inhibitor, once daily in patients with moderately to severely active systemic lupus erythematosus. The SLEek study met the primary endpoint of SLE Responder Index and steroid dose less than or equal to 10 mg prednisone equivalent once per day at week 24 in the upadacitinib 30 mg group. Based on the results, AbbVie is advancing its clinical program of upadacitinib in SLE to Phase 3. ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options ABBV AbbVie $153.67 / -3.155 (-2.01%) 03/23/23 AbbVie says Phase 3 INSPIRE study met primary, secondary endpoints 03/22/23 AbbVie receives CRL from FDA for NDA for ABBV-951 03/19/23 AbbVie announces late-breaking results for SKYRIZI study 02/27/23 AbbVie receives CHMP opinion recommending approval for upadacitinib ABBV AbbVie $153.67 / -3.155 (-2.01%) 03/16/23 Chardan Immunome price target lowered to $8 from $9 at Chardan 03/01/23 Guggenheim Guggenheim starts AbbVie with a Buy on diversified growth 02/28/23 Guggenheim AbbVie initiated with a Buy at Guggenheim 02/22/23 BMO Capital AbCellera price target lowered to $32 from $40 at BMO Capital ABBV AbbVie $153.67 / -3.155 (-2.01%) 02/09/23 AbbVie sees Q1 adjusted EPS $2.39-$2.49, consensus $3.08 02/09/23 AbbVie sees FY23 revenue about $52B, consensus $54.21B 02/09/23 AbbVie sees FY23 adjusted EPS $10.70-$11.10, consensus $11.65 02/09/23 AbbVie reports Q4 adjusted EPS $3.60, consensus $3.56 ABBV AbbVie $153.67 / -3.155 (-2.01%) 02/06/23 AbbVie looking for next hit drug after competitors target Humira, WSJ reports 01/31/23 AbbVie's Humira drug faces competition in the U.S., FT reports 12/03/22 Buy AbbVie, stock still worth owning even as Humira fades, Barron's says 11/16/22 Optum Rx puts biosimilars on formulary against AbbVie's Humira, Bloomberg says ABBV AbbVie $153.67 / -3.155 (-2.01%) 03/22/23 What You Missed On Wall Street On Wednesday 03/22/23 What You Missed On Wall Street This Morning 03/01/23 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 02/22/23 What You Missed On Wall Street On Wednesday 05/21/23 PDUFA Date for Epcoritamab (DuoBody-CD3xCD20) 05/05/23 AbbVie Inc. ABBV AbbVie $153.67 / -3.155 (-2.01%) 02/09/23 Unusually active option classes on open February 9th 01/18/23 Unusually active option classes on open January 18th 10/28/22 Unusually active option classes on open October 28th
Hot Stocks	AbbVie says Phase 3 INSPIRE study met primary, secondary endpoints » 08:31 03/23/23 03/23 08:31 03/23/23 08:31 ABBV AbbVie $153.67 / -3.155 (-2.01%) AbbVie announced positive… AbbVie announced positive top-line results from INSPIRE, a Phase 3 induction study, showing risankizumab met the primary endpoint of clinical remission at week 12, as well as all secondary endpoints in adult patients with moderately to severely active ulcerative colitis. In the study, 20.3% of patients receiving risankizumab achieved clinical remission compared to 6.2% of patients receiving placebo. The INSPIRE study enrolled patients that demonstrated intolerance or inadequate response to conventional therapies and/or advanced therapies. ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options ABBV AbbVie $153.67 / -3.155 (-2.01%) 03/22/23 AbbVie receives CRL from FDA for NDA for ABBV-951 03/19/23 AbbVie announces late-breaking results for SKYRIZI study 02/27/23 AbbVie receives CHMP opinion recommending approval for upadacitinib 02/23/23 AbbVie, Capsida announce expanded genetic medicines for eye diseases pact ABBV AbbVie $153.67 / -3.155 (-2.01%) 03/16/23 Chardan Immunome price target lowered to $8 from $9 at Chardan 03/01/23 Guggenheim Guggenheim starts AbbVie with a Buy on diversified growth 02/28/23 Guggenheim AbbVie initiated with a Buy at Guggenheim 02/22/23 BMO Capital AbCellera price target lowered to $32 from $40 at BMO Capital ABBV AbbVie $153.67 / -3.155 (-2.01%) 02/09/23 AbbVie sees Q1 adjusted EPS $2.39-$2.49, consensus $3.08 02/09/23 AbbVie sees FY23 revenue about $52B, consensus $54.21B 02/09/23 AbbVie sees FY23 adjusted EPS $10.70-$11.10, consensus $11.65 02/09/23 AbbVie reports Q4 adjusted EPS $3.60, consensus $3.56 ABBV AbbVie $153.67 / -3.155 (-2.01%) 02/06/23 AbbVie looking for next hit drug after competitors target Humira, WSJ reports 01/31/23 AbbVie's Humira drug faces competition in the U.S., FT reports 12/03/22 Buy AbbVie, stock still worth owning even as Humira fades, Barron's says 11/16/22 Optum Rx puts biosimilars on formulary against AbbVie's Humira, Bloomberg says ABBV AbbVie $153.67 / -3.155 (-2.01%) 03/22/23 What You Missed On Wall Street On Wednesday 03/22/23 What You Missed On Wall Street This Morning 03/01/23 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 02/22/23 What You Missed On Wall Street On Wednesday 05/21/23 PDUFA Date for Epcoritamab (DuoBody-CD3xCD20) 05/05/23 AbbVie Inc. ABBV AbbVie $153.67 / -3.155 (-2.01%) 02/09/23 Unusually active option classes on open February 9th 01/18/23 Unusually active option classes on open January 18th 10/28/22 Unusually active option classes on open October 28th

Wednesday
On The Fly	What You Missed On Wall Street On Wednesday » 16:31 03/22/23 03/22 16:31 03/22/23 16:31 NKE Nike $119.49 / -6.09 (-4.85%) , ABBV AbbVie $153.67 / -3.155 (-2.01%) , PACW PacWest Bancorp $10.10 / -2.06 (-16.94%) , GME GameStop $23.83 / +6.2 (+35.17%) , SPX S&P 500 / + , SPY SPDR S&P 500 ETF Trust $392.13 / -6.76 (-1.69%) , $ECON Economic Data $0.00 / + (+0.00%) , META Meta Platforms $199.69 / -2.42 (-1.20%) , SPOT Spotify $128.20 / -0.57 (-0.44%) , ALT Altimmune $4.19 / -0.76 (-15.35%) , DNUT Krispy Kreme $15.33 / +0.915 (+6.35%) , LAZR Luminar $6.61 / -1.12 (-14.50%) , NVS Novartis $81.97 / -1.695 (-2.03%) , UBS UBS $20.39 / -0.665 (-3.16%) , BABA Alibaba $83.64 / -0.06 (-0.07%) , BA Boeing $196.11 / -8.595 (-4.20%) , GOOG Alphabet $104.27 / -1.59 (-1.50%) , GOOGL Alphabet $103.38 / -1.53 (-1.46%) , ETNB 89bio $13.68 / +2.75 (+25.16%) , CVNA Carvana $8.42 / +0.49 (+6.18%) , OLLI Ollie's Bargain Outlet $58.43 / +5.19 (+9.75%) , SCHW Charles Schwab $56.28 / -3.21 (-5.40%) , HST Host Hotels $15.07 / -0.81 (-5.10%) , ARRY Array Technologies $19.61 / +0.88 (+4.70%) , HSY Hershey $242.70 / -0.305 (-0.13%) , WOOF Petco $8.38 / -1.775 (-17.49%) , HQY HealthEquity $57.14 / -1.19 (-2.04%) , SPPI Spectrum / + Get caught up quickly on… Open Full Text ShowHide Related Items >><< Company News Street Research Earnings Syndicate Periodicals On The Fly Events Options Technical Analysis WOOF UBS SPX SPPI SPOT SCHW PACW OLLI NVS NKE META LAZR HSY HST HQY GOOG GME ETNB DNUT CVNA BABA BA ARRY ALT ABBV WOOF Petco $8.38 / -1.775 (-17.49%) 03/22/23 Petco falls 7% to $9.44 after Q4 results, FY23 guidance 03/22/23 Freshpet, Petco announce delivery partnership 03/22/23 Petco expects to make $100M in principal payments on term loan in FY23 03/22/23 Petco sees FY23 CapEx $225M-$250M UBS UBS $20.39 / -0.665 (-3.16%) 03/20/23 S&P revises UBS Group outlook to Negative, affirms ratings 03/20/23 UBS rises 7.9% 03/19/23 Fly Intel: Top five weekend stock stories 03/19/23 Credit Suisse says UBS confident staff employment will be continued SPX S&P 500 / + 03/22/23 Senators Scott, Warren unveil bipartisan Fed oversight legislation 03/01/23 Einhorn says not invested long in artificial intelligence companies 03/01/23 Einhorn says investors should be 'bearish on stocks and bullish on inflation' 12/14/22 SEC proposes rules to enhance competition for retail order flow execution SPPI Spectrum / + 02/08/23 CMS grants Spectrum permanent J-Code for Rolvedon injection 01/04/23 Spectrum announces that CMO Francois Lebel, M.D. steps down 12/06/22 Spectrum announces Rolvedon added to latest NCCN Guidelines 11/25/22 Spectrum receives CRL from FDA regarding NDA for poziotinib SPOT Spotify $128.20 / -0.57 (-0.44%) 03/08/23 Spotify introduces Spotify for Podcasters, offering more 'access to innovation' 01/31/23 Spotify rises 9.8% 01/31/23 Spotify reports Q4 MAUs up 20% y/y to 489M 01/26/23 Spotify tweets 'everything's looking much better now' SCHW Charles Schwab $56.28 / -3.21 (-5.40%) 03/20/23 Charles Schwab director buys $200K in common stock 03/17/23 Charles Schwab reports $16.5B in core net new assets over past five trading days 03/16/23 Charles Schwab director buys $233.5K in common stock 03/15/23 Charles Schwab director buys $2.0M in common stock PACW PacWest Bancorp $10.10 / -2.06 (-16.94%) 03/22/23 Pacific Western Bank determines not to move forward with capital raise 03/22/23 Pacific Western Bank reports $11.4B in available cash as of March 20 03/20/23 PacWest Bancorp says bank continues to have 'solid liquidity' 03/16/23 PacWest Bancorp trading resumes OLLI Ollie's Bargain Outlet $58.43 / +5.19 (+9.75%) 03/22/23 Ollie's Bargain Outlet jumps 11% to $59.00 after Q4 earnings beat and FY23 guide 10/17/22 Ollie's Bargain Outlet appoints Rob Helm as CFO NVS Novartis $81.97 / -1.695 (-2.03%) 03/21/23 Novartis alpelisib granted FDA orphan designation 03/21/23 Novartis' Sandoz receives FDA approval for biosimilar Hyrimoz HCF 03/17/23 Novartis terminates collaboration and license pact with Sangamo 03/16/23 Novartis' Tafinlar + Mekinist approved by FDA for pediatric patients NKE Nike $119.49 / -6.09 (-4.85%) 03/21/23 Nike pares afterhours gains, down 0.9% after Q4 and FY23 outlook 03/21/23 Nike jumps 4% to $131.00 after Q3 earnings beat 03/21/23 Nike reports Q3-end inventories at $8.9B, up 16% from last year 03/21/23 Nike reports Direct sales up 17% at $5.3B META Meta Platforms $199.69 / -2.42 (-1.20%) 03/21/23 Nvidia announces availability of new products featuring H100 Tensor Core GPU 03/15/23 Facebook Ireland violated law over data use, Amsterdam court ruled 03/15/23 Oportun Financial expands executive team with key new hires 03/14/23 Meta targeting summer to complete analysis from hybrid work year of learning LAZR Luminar $6.61 / -1.12 (-14.50%) 02/28/23 Luminar off earlier highs, goes red after Q4 business update at 'Luminar Day' 02/28/23 Luminar unveils new Iris+ sensor, announces Luminar AI Engine 02/28/23 Luminar partners with Swiss Re to launch insurance program 02/22/23 Luminar up 15% to $6.62 after announcing expansion of Mercedes-Benz partnership HSY Hershey $242.70 / -0.305 (-0.13%) 02/21/23 Bath & Body Works appoints Hershey CFO Voskuil to board 12/07/22 Hershey announces first bilingual manufacturing facility 10/20/22 Hershey signs new solar power purchase agreement with National Grid Renewables HST Host Hotels $15.07 / -0.81 (-5.10%) 02/15/23 Host Hotels provides RevPAR outlook for next three quarters 02/15/23 Host Hotels provides update on Hurricane Ian damage 12/15/22 Host Hotels board authorizes special dividend of 20c per share 11/29/22 Host Hotels appoints Mari Sifo as EVP, Chief Human Resources Officer HQY HealthEquity $57.14 / -1.19 (-2.04%) 01/09/23 HealthEquity announces HSA sales outlook 09/22/22 Director of HealthEquity Sacks sells $1.8M in company shares 09/22/22 Director of HealthEquity Sacks sells $1.8M in company shares GOOG Alphabet $104.27 / -1.59 (-1.50%) 03/21/23 Nvidia says Google Cloud integrating newly launched L4 GPU, Vertex AI 03/17/23 YouTube restores Donald Trump's channel 03/17/23 Google ends enterprise sales of Google Glass 03/16/23 YouTube TV raises monthly price to $72.99 from $64.99 GME GameStop $23.83 / +6.2 (+35.17%) 03/22/23 GameStop rises 40.7% 03/22/23 GameStop rises 32.9% 03/22/23 GameStop rises 45.0% 03/21/23 GameStop jumps nearly 33% to over $23 after reporting Q4 profit ETNB 89bio $13.68 / +2.75 (+25.16%) 03/22/23 89bio up 47% to $16.10 after announcing positive pegozafermin trial data 03/22/23 89bio's pegozafermin trial statistically significant in critical histology 03/05/23 89bio presents new analysis of data from Phase 2 ENTRIGUE trial of pegozafermin 12/12/22 89bio announces publication of Phase 1b/2a pegozafermin study results DNUT Krispy Kreme $15.33 / +0.915 (+6.35%) 02/27/23 Krispy Kreme confirms expanded market test with McDonald's 12/15/22 Krispy Kreme down 4% amid investor day presentations 10/18/22 Krispy Kreme up 8% after reports of McDonald's testing donut sales partnership 09/26/22 Krispy Kreme offers free coffee on National Coffee Day CVNA Carvana $8.42 / +0.49 (+6.18%) 03/22/23 Major Carvana bondholders reportedly to oppose restructuring plan 03/22/23 Carvana rises 23.6% 03/22/23 Carvana rises 16.3% 03/22/23 Carvana rises 22.8% BABA Alibaba $83.64 / -0.06 (-0.07%) 02/23/23 Alibaba jumps 6% to $100.65 after Q3 results beat estimates 02/23/23 Alibaba CEO sees 'continued recovery in consumer sentiment' 02/14/23 Appaloosa takes stake in Disney, exits position in Mosaic 01/31/23 Iqvia teams with Alibaba for cloud commercial & clinical solutions in China BA Boeing $196.11 / -8.595 (-4.20%) 03/17/23 Boeing awarded $1.95B Army contract modification 03/14/23 Boeing reports 28 commercial airplane deliveries, 5 orders in February 03/14/23 Saudi Arabian Airlines selects up to 49 Boeing 787 Dreamliners 03/14/23 Riyadh Air choses Boeing 787 Dreamliner to power its global launch ARRY Array Technologies $19.61 / +0.88 (+4.70%) 03/15/23 Array Technologies reschedules earnings, needs more time to file annual report 03/03/23 Avangrid announces intent to deploy more than $30M in solar trackers from Array 01/30/23 Array Technologies names Manning as Chief Operations Officer 11/08/22 Array Technologies appoints Jokinen to board of directors ALT Altimmune $4.19 / -0.76 (-15.35%) 03/21/23 Altimmune falls 35% to $7.15 after initerim MOMENTUM Phase 2 trial data 03/21/23 Altimmune announces reuslts from interim analysis of MOMENTUM Phase 2 trial 01/04/23 Altimmune appoints Jordt as Chief Business Officer 12/20/22 Altimmune announces topline results from 24-week trial of pemvidutide ABBV AbbVie $153.67 / -3.155 (-2.01%) 03/22/23 AbbVie receives CRL from FDA for NDA for ABBV-951 03/19/23 AbbVie announces late-breaking results for SKYRIZI study 02/27/23 AbbVie receives CHMP opinion recommending approval for upadacitinib 02/23/23 AbbVie, Capsida announce expanded genetic medicines for eye diseases pact NKE ABBV PACW GME SPX SPY $ECON META SPOT ALT DNUT LAZR NVS UBS BABA BA GOOG GOOGL ETNB CVNA OLLI SCHW HST ARRY HSY WOOF HQY SPPI NKE Nike $119.49 / -6.09 (-4.85%) 03/22/23 BofA Nike inventory progress coming at expense of margins, says BofA 03/22/23 Evercore ISI Nike added to 'Tactical Outperform' list at Evercore ISI 03/22/23 Piper Sandler Nike price target raised to $112 from $105 at Piper Sandler 03/22/23 Jefferies Nike price target raised to $160 from $140 at Jefferies ABBV AbbVie $153.67 / -3.155 (-2.01%) 03/16/23 Chardan Immunome price target lowered to $8 from $9 at Chardan 03/01/23 Guggenheim Guggenheim starts AbbVie with a Buy on diversified growth 02/28/23 Guggenheim AbbVie initiated with a Buy at Guggenheim 02/22/23 BMO Capital AbCellera price target lowered to $32 from $40 at BMO Capital PACW PacWest Bancorp $10.10 / -2.06 (-16.94%) 03/23/23 Piper Sandler PacWest 'can make it to the other side,' says Piper Sandler 03/22/23 RBC Capital PacWest provides detailed update on deposit balances, says RBC Capital 03/20/23 Piper Sandler Piper confident PacWest can make it through liquidity crunch 03/20/23 DA Davidson PacWest Bancorp price target lowered to $26 from $29 at DA Davidson GME GameStop $23.83 / +6.2 (+35.17%) 12/08/22 Wedbush GameStop price target lowered to $5.30 from $6 at Wedbush 10/13/22 Jefferies GameStop transferred with a Hold at Jefferies 08/16/22 B. Riley B. Riley downgrades 'meme stock' Bed Bath & Beyond to Sell 07/22/22 Wedbush GameStop price target lowered to $7.50 from $30 at Wedbush SPX S&P 500 / + 03/20/23 Citi Citi sees 25 basis point hike from Fed on Wednesday 03/17/23 JPMorgan JPMorgan expects 25 point hike from Federal Reserve next week 03/07/23 JPMorgan JPMorgan says 'spooked' Powell opened door to 50 point hike 02/13/23 JPMorgan Stock market risk/reward 'skewed to the downside,' says JPMorgan SPY SPDR S&P 500 ETF Trust $392.13 / -6.76 (-1.69%) $ECON Economic Data $0.00 / + (+0.00%) META Meta Platforms $199.69 / -2.42 (-1.20%) 03/22/23 KeyBanc Meta Platforms upgraded to Overweight from Sector Weight at KeyBanc 03/21/23 Morgan Stanley Meta Platforms upgraded to Overweight from Equal Weight at Morgan Stanley 03/20/23 Loop Capital Meta Platforms price target raised to $220 from $188 at Loop Capital 03/20/23 Edward Jones Meta Platforms upgraded to Buy from Hold at Edward Jones SPOT Spotify $128.20 / -0.57 (-0.44%) 03/22/23 Guggenheim Spotify upgraded to Buy at Guggenheim on music industry growth potential 03/22/23 Guggenheim Spotify upgraded to Buy from Neutral at Guggenheim 03/10/23 BofA Spotify price target raised to $143 from $120 at BofA 03/01/23 Redburn Spotify upgraded to Buy from Neutral at Redburn ALT Altimmune $4.19 / -0.76 (-15.35%) 03/22/23 Stifel Stifel argues sympathy trading not a predictor for Viking's pending VK2735 data 03/21/23 Goldman Sachs Altimmune downgraded to Neutral from Buy at Goldman Sachs 03/21/23 William Blair William Blair says Viking bull thesis intact after Altimmune data 03/21/23 H.C. Wainwright Altimmune attractive after 'overdone' selloff, says H.C. Wainwright DNUT Krispy Kreme $15.33 / +0.915 (+6.35%) 03/22/23 Truist Krispy Kreme upgraded to Buy at Truist on volume growth, FX tailwinds 03/22/23 Truist Krispy Kreme upgraded to Buy from Hold at Truist 02/14/23 HSBC Krispy Kreme price target lowered to $14 from $15 at HSBC 01/17/23 Morgan Stanley Krispy Kreme downgraded to Equal Weight from Overweight at Morgan Stanley LAZR Luminar $6.61 / -1.12 (-14.50%) 03/21/23 Goldman Sachs Luminar downgraded to Sell from Neutral at Goldman Sachs 03/14/23 Citi Luminar price target lowered to $19 from $20 at Citi 03/06/23 JPMorgan Luminar price target raised to $20 from $15 at JPMorgan 03/01/23 Deutsche Bank Luminar price target lowered to $14 from $15 at Deutsche Bank NVS Novartis $81.97 / -1.695 (-2.03%) 01/26/23 Citi Novartis downgraded to Neutral from Buy at Citi 01/24/23 Lake Street Harrow Health price target raised to $24 from $17 at Lake Street 01/06/23 Morgan Stanley Novartis downgraded to Underweight from Equal Weight at Morgan Stanley 01/03/23 JPMorgan Novartis upgraded to Neutral from Underweight at JPMorgan UBS UBS $20.39 / -0.665 (-3.16%) 03/20/23 Barclays European Banks sector view downgraded to Neutral at Barclays 03/20/23 Societe Generale UBS downgraded to Hold from Buy at Societe Generale 03/20/23 Keefe Bruyette UBS downgraded to Underperform from Market Perform at Keefe Bruyette 03/20/23 BofA UBS upgraded to Buy from Neutral at BofA BABA Alibaba $83.64 / -0.06 (-0.07%) 02/28/23 Susquehanna Alibaba price target lowered to $175 from $185 at Susquehanna 02/24/23 UBS Vipshop upgraded to Buy at UBS on apparel demand recovery 02/24/23 Truist Alibaba price target raised to $130 from $120 at Truist 02/24/23 KGI Securities Alibaba upgraded to Outperform from Neutral at KGI Securities BA Boeing $196.11 / -8.595 (-4.20%) 03/23/23 Susquehanna Boeing orders from Japan sign of strong demand, says Susquehanna 03/23/23 Wolfe Research Boeing under $200 brings attractive entry point, says Wolfe Research 03/22/23 Wells Fargo Boeing price target lowered to $230 from $240 at Wells Fargo 03/16/23 Northcoast Boeing initiated with a Neutral at Northcoast GOOG Alphabet $104.27 / -1.59 (-1.50%) 03/21/23 Morgan Stanley Microsoft app store longer-term Apple risk 'worth watching,' says Morgan Stanley 03/20/23 Stifel Alphabet resumed with a Buy at Stifel 03/17/23 Exane BNP Paribas Alphabet upgraded to Outperform from Neutral at Exane BNP Paribas 03/16/23 Macquarie Microsoft 'clear winner' in ongoing generative AI fight, says Macquarie GOOGL Alphabet $103.38 / -1.53 (-1.46%) ETNB 89bio $13.68 / +2.75 (+25.16%) 03/22/23 Oppenheimer 89bio price target raised to $33 from $18 at Oppenheimer 03/22/23 H.C. Wainwright 89bio price target raised to $30 from $25 at H.C. Wainwright 03/22/23 Raymond James Raymond James doubles 89bio price target to $50 after FGF21 'wins again' 03/22/23 Raymond James 89bio price target raised to $50 from $25 at Raymond James CVNA Carvana $8.42 / +0.49 (+6.18%) 03/23/23 JPMorgan Carvana business de-scaling overshadows cost cuts, says JPMorgan 03/23/23 Citi Citi encouraged with accelerating retail unit sales at Carvana 03/22/23 Raymond James Carvana navigating difficult operating environment, says Raymond James 02/27/23 Citi Carvana price target raised to $11 from $5.50 at Citi OLLI Ollie's Bargain Outlet $58.43 / +5.19 (+9.75%) 03/22/23 Goldman Sachs Ollie's Bargain Outlet price target raised to $61 from $56 at Goldman Sachs 02/28/23 Piper Sandler Ollie's Bargain Outlet price target raised to $72 from $60 at Piper Sandler 02/06/23 Wells Fargo Ollie's Bargain Outlet price target raised to $67 from $60 at Wells Fargo 12/08/22 Jefferies Ollie's Bargain Outlet price target lowered to $60 from $65 at Jefferies SCHW Charles Schwab $56.28 / -3.21 (-5.40%) 03/22/23 Barclays Charles Schwab price target lowered to $61 from $79 at Barclays 03/15/23 Credit Suisse Charles Schwab upgraded to Outperform from Neutral at Credit Suisse 03/14/23 JPMorgan Schwab funding concerns 'significantly de-risked,' says JPMorgan 03/14/23 Piper Sandler Charles Schwab price target lowered to $95 from $100 at Piper Sandler HST Host Hotels $15.07 / -0.81 (-5.10%) 03/22/23 Compass Point Host Hotels downgraded to Neutral from Buy at Compass Point 02/16/23 Stifel Host Hotels price target lowered to $21 from $22 at Stifel 01/09/23 Jefferies Hilton downgraded to Hold from Buy at Jefferies 01/09/23 Jefferies Marriott downgraded to Hold from Buy at Jefferies ARRY Array Technologies $19.61 / +0.88 (+4.70%) 03/22/23 Guggenheim Array Technologies price target lowered to $35 from $36 at Guggenheim 03/09/23 Citi Array Technologies initiated with a Neutral at Citi 03/07/23 Piper Sandler Array Technologies price target lowered to $26 from $28 at Piper Sandler 03/01/23 Scotiabank Array Technologies initiated with an Outperform at Scotiabank HSY Hershey $242.70 / -0.305 (-0.13%) 03/20/23 Deutsche Bank Hershey price target lowered to $237 from $246 at Deutsche Bank 03/17/23 Erste Group Hershey upgraded to Buy from Hold at Erste Group 02/02/23 Goldman Sachs Hershey price target raised to $277 from $255 at Goldman Sachs 01/06/23 Evercore ISI Hershey downgraded to In Line from Outperform at Evercore ISI WOOF Petco $8.38 / -1.775 (-17.49%) 03/23/23 Baird Petco price target lowered to $11 from $14 at Baird 03/23/23 Morgan Stanley Petco price target lowered to $10 from $12 at Morgan Stanley 03/22/23 Baird Petco price target lowered to $11 from $14 at Baird 03/15/23 Wedbush Petco price target lowered to $12 from $17 at Wedbush HQY HealthEquity $57.14 / -1.19 (-2.04%) 02/03/23 Wells Fargo HealthEquity price target lowered to $89 from $101 at Wells Fargo 01/24/23 Deutsche Bank HealthEquity price target raised to $72 from $68 at Deutsche Bank 01/03/23 BTIG Sharecare named Top Pick for first half of 2023 at BTIG 12/16/22 Baird HealthEquity bullish Fresh Pick designation extended at Baird SPPI Spectrum / + 01/31/23 H.C. Wainwright Spectrum Q4 sales dramatically beat estimates, says H.C. Wainwright 11/25/22 H.C. Wainwright Spectrum price target lowered to $4 from $6 at H.C. Wainwright 11/16/22 B. Riley Spectrum downgraded to Neutral from Buy at B. Riley 09/23/22 H.C. Wainwright Spectrum price target lowered to $6 from $9 at H.C. Wainwright WOOF UBS SPPI SPOT SCHW PACW OLLI NVS NKE META LAZR HSY HST HQY GOOG GME ETNB DNUT CVNA BABA BA ARRY ALT ABBV WOOF Petco $8.38 / -1.775 (-17.49%) 03/22/23 Petco sees FY23 revenue $6.15B-$6.275B, consensus $6.36B 03/22/23 Petco reports Q4 adjusted EPS 23c, consensus 24c UBS UBS $20.39 / -0.665 (-3.16%) 01/31/23 UBS reports Q4 EPS 50c, profit before tax $1.9B 10/25/22 UBS reports Q3 EPS 52c, net profit $1.7B SPPI Spectrum / + 03/22/23 Spectrum reports Q4 EPS (5c), consensus (11c) 01/31/23 Spectrum rallies after preliminary Q4 sales crush estimates 11/10/22 Spectrum reports Q3 EPS (12c), consensus (15c) SPOT Spotify $128.20 / -0.57 (-0.44%) 01/31/23 Spotify sees Q1 revenue EUR 3.1B, gross margin 24.9% 01/31/23 Spotify reports Q4 EPS (EUR 1.40) vs. (EUR 0.20) last year 10/25/22 Spotify reports Q3 Operating loss EUR (228M) vs. profit EUR 75M prior SCHW Charles Schwab $56.28 / -3.21 (-5.40%) 01/18/23 Charles Schwab reports Q4 adjusted EPS $1.07, consensus $1.09 01/17/23 Notable companies reporting before tomorrow's open 10/27/22 Charles Schwab backs 11%-13% year-over-year revenue growth outlook PACW PacWest Bancorp $10.10 / -2.06 (-16.94%) 01/26/23 PacWest Bancorp reports Q4 EPS 33c, consensus 97c 10/19/22 PacWest Bancorp reports Q3 EPS 1.02, consensus $1.07 OLLI Ollie's Bargain Outlet $58.43 / +5.19 (+9.75%) 03/22/23 Ollie's Bargain Outlet sees 2023 adjusted EPS $2.49-$2.58, consensus $2.38 03/22/23 Ollie's Bargain Outlet reports Q4 adjusted EPS 84c, consenus 79c 03/21/23 Notable companies reporting before tomorrow's open NVS Novartis $81.97 / -1.695 (-2.03%) 02/01/23 Novartis sees core operating income to grow mid single digit percentage in 2023 02/01/23 Novartis reports Q4 core EPS $1.52, consensus $1.44 10/25/22 Novartis confirms mid single digit sales, core operating income guidance 10/25/22 Novartis reports Q3 core EPS $1.58 vs. $1.71 last year NKE Nike $119.49 / -6.09 (-4.85%) 03/21/23 Nike sees FY23 revenue up high single digits, gross margins down 250bps 03/21/23 Nike reports Q3 EPS 79c, consensus 55c 03/21/23 Notable companies reporting after market close 12/20/22 Nike sees FY23 revenue growth in mid teens, consensus $49.01B META Meta Platforms $199.69 / -2.42 (-1.20%) 02/01/23 Meta Platforms sees Q1 revenue $26B-$28.5B, consensus $27.14B 02/01/23 Meta Platforms reports Q4 EPS $1.76, consensus $2.22 02/01/23 Notable companies reporting after market close 11/09/22 Meta Platforms backs Q4 revenue outlook $30B-$32.5B, consensus $31.52B LAZR Luminar $6.61 / -1.12 (-14.50%) 02/28/23 Luminar sees FY23 revenue growth of 'at least 100%,' consensus $116.14M 02/28/23 Luminar reports Q4 EPS (26c), consensus (21c) 11/02/22 Luminar reports Q3 EPS (18c), consensus (20c) 11/02/22 Notable companies reporting after market close HSY Hershey $242.70 / -0.305 (-0.13%) 03/22/23 Hershey backs FY23 adjusted EPS growth view 9%-11%, consensus $9.35 02/02/23 Hershey sees FY23 adjusted EPS up 9%-11%, consensus $8.94 02/02/23 Hershey reports Q4 adjusted EPS $2.02, consensus $1.77 02/01/23 Notable companies reporting before tomorrow's open HST Host Hotels $15.07 / -0.81 (-5.10%) 02/15/23 Host Hotels reports Q4 EPS 20c, consensus 19c 11/02/22 Host Hotels reports Q3 EPS 16c, consensus 17c HQY HealthEquity $57.14 / -1.19 (-2.04%) 03/21/23 HealthEquity sees FY24 EPS $1.74-$1.87, consensus $1.76 03/21/23 HealthEquity reports Q4 EPS 0c, consensus 35c 12/06/22 HealthEquity sees FY24 revenue $950M-$970M, consensus $948.4M 12/06/22 HealthEquity raises FY23 EPS view to $1.26-$1.35 from $1.23-$1.32 GOOG Alphabet $104.27 / -1.59 (-1.50%) 02/02/23 Alphabet reports Q4 EPS $1.05, consensus $1.18 02/02/23 Notable companies reporting after market close 10/25/22 Alphabet reports Q3 EPS $1.06, consensus $1.25 10/25/22 Notable companies reporting after market close GME GameStop $23.83 / +6.2 (+35.17%) 03/21/23 GameStop reports Q4 EPS 16c, consensus (13c) 12/07/22 GameStop reports Q3 EPS (31c), consensus (28c) ETNB 89bio $13.68 / +2.75 (+25.16%) 03/10/23 89bio reports Q4 EPS (48c), consensus (69c) 11/10/22 89bio reports Q3 EPS (57c), consensus (80c) DNUT Krispy Kreme $15.33 / +0.915 (+6.35%) 02/15/23 Krispy Kreme sees FY23 adjusted EPS 31c-34c, consensus 36c 02/15/23 Krispy Kreme reports Q4 adjusted EPS 11c, consensus 10c 12/15/22 Krispy Kreme sees FY26 revenue about $2.15B, adjusted EPS about 53c 12/15/22 Krispy Kreme sees FY23 revenue up low double digits in constant currency CVNA Carvana $8.42 / +0.49 (+6.18%) 03/22/23 Carvana sees Q1 revenue $2.4B-$2.6B, consensus $2.7B 02/23/23 Carvana reports Q4 EPS ($7.61) vs ($1.02) last year 02/23/23 Notable companies reporting after market close 11/03/22 Carvana sees sequential reduction in retail units sold in Q4 BABA Alibaba $83.64 / -0.06 (-0.07%) 02/23/23 Alibaba reports Q3 adjusted EPS $2.79, consensus $2.37 02/22/23 Notable companies reporting before tomorrow's open 11/17/22 Alibaba reports Q2 adjusted EPS $1.82, consensus $1.64 BA Boeing $196.11 / -8.595 (-4.20%) 01/25/23 Boeing reports Q4 core EPS ($1.75), consensus 26c 01/24/23 Notable companies reporting before tomorrow's open 10/26/22 Boeing reports Q3 core EPS ($6.18), consensus 2c ARRY Array Technologies $19.61 / +0.88 (+4.70%) 03/21/23 Array Technologies sees FY23 adjusted EPS 75c-85c, consensus 78c 03/21/23 Array Technologies reports Q4 adjusted EPS 10c, consensus 8c 03/02/23 Array Technologies sees 2023 adjusted EPS 75c-85c, consensus 95c ALT Altimmune $4.19 / -0.76 (-15.35%) 02/28/23 Altimmune reports Q4 EPS (43c), consensus (50c) 11/10/22 Altimmune reports Q3 EPS (48c), consensus (50c) ABBV AbbVie $153.67 / -3.155 (-2.01%) 02/09/23 AbbVie sees Q1 adjusted EPS $2.39-$2.49, consensus $3.08 02/09/23 AbbVie sees FY23 revenue about $52B, consensus $54.21B 02/09/23 AbbVie sees FY23 adjusted EPS $10.70-$11.10, consensus $11.65 02/09/23 AbbVie reports Q4 adjusted EPS $3.60, consensus $3.56 24 Mar 10 Mar 02 Aug 29 Jun 22 Apr UBS SPX SPOT SCHW PACW NVS NKE META LAZR HSY GOOG GME DNUT CVNA BABA BA ARRY ABBV $ECON UBS UBS $20.39 / -0.665 (-3.16%) 03/22/23 UBS eyes shrinking Credit Suisse's $10B shipping portfolio, WSJ reports 03/21/23 UBS to enter talks with Michael Klein to unwind First Boston deal, FT says 03/21/23 Credit Suisse ordered to suspend payment to staff of deferred bonuses, FT says 03/21/23 Credit Suisse rescue could spur 'tens of thousands' of layoffs, FT reports SPX S&P 500 / + 03/20/23 Treasury considering expanding FDIC coverage to all deposits, Bloomberg reports 03/14/23 Fed may extend tougher capital restrictions to midsize banks, WSJ says 03/08/23 Biden to propose 25% billionaire tax, Bloomberg says 03/08/23 Biden to propose 25% billionaire tax, Bloomberg says SPOT Spotify $128.20 / -0.57 (-0.44%) 03/15/23 Spotify's Soderstrom says HiFi still 'coming at some point,' The Verge reports 03/08/23 Spotify narrows its focus in podcasting business, Verge says 02/28/23 EU narrows Apple probe to app restrictions, FT reports 02/10/23 ValueAct takes stake in Spotify, Bloomberg reports SCHW Charles Schwab $56.28 / -3.21 (-5.40%) 03/14/23 Ron Baron told CNBC bought Charles Schwab shares yesterday 02/27/23 Schwab to face suit seeking to unwind TD Ameritrade deal, Bloomberg says 01/07/23 Charles Schwab stock ready to put 2022 behind it, time to buy, Barron's says 12/10/22 Microsoft, Arista among stocks that can survive a triple whammy, Barron's says PACW PacWest Bancorp $10.10 / -2.06 (-16.94%) 03/16/23 PacWest in talks for liquidity boost, Reuters says 03/16/23 PacWest in talks for liquidity boost from Atlas SP Partners, Reuters says NVS Novartis $81.97 / -1.695 (-2.03%) 03/22/23 Novartis halts Leqvio heart attack prevention trial, Reuters reports 02/08/23 Avrobio exploring potential sale after approach, Street Insider says 12/29/22 Novartis to pay $245M to settle lawsuit on Exforge medicine, Bloomberg reports 11/16/22 Novartis exploring sale of ophthalmology, respiratory units, Bloomberg says NKE Nike $119.49 / -6.09 (-4.85%) 12/05/22 Nike cut ties with Kyrie Irving, The Athletic reports 11/25/22 Brookfield acquired Nike label supplier Trimco Group, Bloomberg reports 11/15/22 Nike to open online store for virtual sneakers, Bloomberg reports 10/15/22 Shortages have turned to gluts, off-price retailers could benefit, Barron's says META Meta Platforms $199.69 / -2.42 (-1.20%) 03/21/23 TikTok reassures advertisers over U.S. ban threat, WSJ reports 03/20/23 TikTok to tell Congress it has 150M monthly active U.S. users, Reuters reports 03/19/23 Meta rolling out verified subscription service in U.S., WSJ reports 03/17/23 DOJ investigating ByteDance for surveillance of American citizens, NY Times says LAZR Luminar $6.61 / -1.12 (-14.50%) 03/20/23 Luminar accused of passing off next-gen chip design of rival as own, Forbes says 01/06/23 Luminar falls after Citron sees shares heading below $1 01/06/23 Luminar shares heading to under $1, Citron Research says 10/01/22 SPAC bubble has burst, Blue Owl Luminar still have potential, Barron's says HSY Hershey $242.70 / -0.305 (-0.13%) 12/30/22 Hershey sued over metals content in dark chocolate, Reuters says 12/19/22 Hershey among brands called out by Consumer Reports for lead exposure GOOG Alphabet $104.27 / -1.59 (-1.50%) 03/22/23 EU set to approve Google's takeover of Photomath, Reuters reports 03/21/23 Google offers early access to Bard AI, Verge reports 03/21/23 Pinduoduo 'strongly' rejects accusation that app is malicious GME GameStop $23.83 / +6.2 (+35.17%) 02/02/23 Ryan Cohen amasses sizable stake in Nordstrom, WSJ reports 01/18/23 Video game sales fell 13% y/y in Europe in December, GI.biz says 01/16/23 Activist investor Ryan Cohen builds stake in Alibaba, WSJ reports 12/05/22 GameStop starts round of layoffs, Axios reports DNUT Krispy Kreme $15.33 / +0.915 (+6.35%) 02/27/23 McDonald's expanding test with Krispy Kreme to over 150 restaurants, CNBC says 10/18/22 McDonald's to sell Krispy Kreme doughnuts, Restaurant Business reports CVNA Carvana $8.42 / +0.49 (+6.18%) 03/22/23 Holders of most of Carvana bonds oppose restructuring plan, Bloomberg says 03/22/23 Carvana looking to restructure $9B debt load, FT reports 01/30/23 Carvana, CarMax pressured by 'abrupt end' to pandemic used-car boom, NYT says 01/13/23 Carvana further cutting staff amid deeper sales slowdown, WSJ says BABA Alibaba $83.64 / -0.06 (-0.07%) 03/22/23 Part of Alibaba shareholder lawsuit dismissed by judge, Reuters reports 02/27/23 Tencent sets up team to work on ChatGPT-style chatbot, Reuters reports 02/08/23 Alibaba says testing its own ChatGPT-style AI tool, Reuters reports BA Boeing $196.11 / -8.595 (-4.20%) 03/22/23 Boeing to take charges on KC-46 tanker amid quality issue, Reuters reports 03/17/23 Netflix, Boeing involved in U.S. business mission to Vietnam, Reuters says 03/16/23 Boeing resumes deliveries of 787 Dreamliner, Reuters reports 03/14/23 Amazon targets 2024 launch of first Kuiper internet satellites, Reuters reports ARRY Array Technologies $19.61 / +0.88 (+4.70%) 12/02/22 Chinese solar producers dodged U.S. tariffs, WSJ reports ABBV AbbVie $153.67 / -3.155 (-2.01%) 02/06/23 AbbVie looking for next hit drug after competitors target Humira, WSJ reports 01/31/23 AbbVie's Humira drug faces competition in the U.S., FT reports 12/03/22 Buy AbbVie, stock still worth owning even as Humira fades, Barron's says 11/16/22 Optum Rx puts biosimilars on formulary against AbbVie's Humira, Bloomberg says $ECON Economic Data $0.00 / + (+0.00%) 03/07/23 Powell tells Congress data from January partly reversed softening trends 01/30/23 Fed likely to raise funds rate benchmark by quarter percentage point, WSJ says WOOF UBS SPY SPX SPPI SPOT SCHW PACW OLLI NVS NKE META HSY GOOG GME ETNB DNUT CVNA BABA BA ABBV WOOF Petco $8.38 / -1.775 (-17.49%) 11/30/22 What You Missed On Wall Street On Wednesday UBS UBS $20.39 / -0.665 (-3.16%) 03/20/23 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations SPY SPDR S&P 500 ETF Trust $392.13 / -6.76 (-1.69%) 03/08/23 What You Missed On Wall Street On Wednesday SPX S&P 500 / + 03/21/23 What You Missed On Wall Street On Tuesday 03/21/23 What You Missed On Wall Street This Morning 03/17/23 What You Missed On Wall Street On Friday SPPI Spectrum / + 11/25/22 What You Missed On Wall Street On Friday SPOT Spotify $128.20 / -0.57 (-0.44%) 03/01/23 What You Missed On Wall Street On Wednesday SCHW Charles Schwab $56.28 / -3.21 (-5.40%) 03/20/23 Fly Insider: Southwest Gas, Pathward among week's notable insider trades 03/15/23 What You Missed On Wall Street On Wednesday PACW PacWest Bancorp $10.10 / -2.06 (-16.94%) 03/20/23 What You Missed On Wall Street On Monday 03/20/23 What You Missed On Wall Street This Morning OLLI Ollie's Bargain Outlet $58.43 / +5.19 (+9.75%) 12/07/22 What You Missed On Wall Street On Wednesday 12/07/22 What You Missed On Wall Street This Morning NVS Novartis $81.97 / -1.695 (-2.03%) 02/10/23 Biotech Alert: Searches spiking for these stocks today 02/01/23 What You Missed On Wall Street This Morning NKE Nike $119.49 / -6.09 (-4.85%) 03/22/23 What You Missed On Wall Street On Wednesday 03/22/23 What You Missed On Wall Street This Morning 03/22/23 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 03/22/23 Fly Intel: Pre-market Movers META Meta Platforms $199.69 / -2.42 (-1.20%) 03/22/23 #SocialStocks: TikTok aims to ease advertisers amid heightened U.S. scrutiny HSY Hershey $242.70 / -0.305 (-0.13%) 02/02/23 What You Missed On Wall Street On Thursday 02/02/23 What You Missed On Wall Street This Morning GOOG Alphabet $104.27 / -1.59 (-1.50%) 03/21/23 What You Missed This Week in Video Games GME GameStop $23.83 / +6.2 (+35.17%) 03/21/23 Fly Intel: After-Hours Movers ETNB 89bio $13.68 / +2.75 (+25.16%) 12/19/22 Trial success is rocketing this NASH stock higher and sinking these peers DNUT Krispy Kreme $15.33 / +0.915 (+6.35%) 02/27/23 What You Missed On Wall Street On Monday CVNA Carvana $8.42 / +0.49 (+6.18%) 02/23/23 Fly Intel: After-Hours Movers 01/17/23 What You Missed On Wall Street On Tuesday BABA Alibaba $83.64 / -0.06 (-0.07%) 02/23/23 What You Missed On Wall Street On Thursday 02/23/23 What You Missed On Wall Street This Morning 02/23/23 Fly Intel: Pre-market Movers BA Boeing $196.11 / -8.595 (-4.20%) 03/16/23 What You Missed On Wall Street On Thursday ABBV AbbVie $153.67 / -3.155 (-2.01%) 03/01/23 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 02/22/23 What You Missed On Wall Street On Wednesday 03/21/23 Global Industrials Conference 03/28/23 Shop Talk 04/24/23 RSA Conference 2023 03/22/23 Petco - WOOF 03/22/23 Ollie's Bargain Outlet - OLLI 03/22/23 Spectrum - SPPI 05/04/23 Host Hotels - HST 05/21/23 PDUFA Date for Epcoritamab (DuoBody-CD3xCD20) 04/18/23 Boeing Co. 05/01/23 Carvana Co. 05/05/23 AbbVie Inc. 05/16/23 The Hershey Company UBS SPX SPPI SPOT SCHW PACW NVS NKE META LAZR HSY HST GOOGL GOOG GME DNUT CVNA BABA BA ARRY ALT ABBV UBS UBS $20.39 / -0.665 (-3.16%) 11/17/22 Largest borrow rate increases among liquid names 11/16/22 Largest borrow rate increases among liquid names SPX S&P 500 / + 09/23/22 SPX Option volume on track for 3.25m contracts, 2nd highest on record SPPI Spectrum / + 03/21/23 Spectrum options imply 25.8% move in share price post-earnings SPOT Spotify $128.20 / -0.57 (-0.44%) 03/06/23 Unusually active option classes on open March 6th 02/10/23 Spotify call volume above normal and directionally bullish 01/31/23 Unusually active option classes on open January 31st 01/23/23 Unusually active option classes on open January 23rd SCHW Charles Schwab $56.28 / -3.21 (-5.40%) 03/16/23 Notable open interest changes for March 16th 03/14/23 Early notable gainers among liquid option names on March 14th PACW PacWest Bancorp $10.10 / -2.06 (-16.94%) 03/20/23 Unusually active option classes on open March 20th 03/17/23 PacWest Bancorp call volume above normal and directionally bullish 03/17/23 Unusually active option classes on open March 17th 03/16/23 Unusually active option classes on open March 16th NVS Novartis $81.97 / -1.695 (-2.03%) 01/09/23 Novartis call volume above normal and directionally bullish 12/16/22 Novartis call volume above normal and directionally bullish 10/06/22 Novartis put volume heavy and directionally bearish NKE Nike $119.49 / -6.09 (-4.85%) 03/21/23 Nike options imply 7.4% move in share price post-earnings 03/21/23 Unusually active option classes on open March 21st 12/22/22 Unusually active option classes on open December 22nd 12/21/22 Early notable gainers among liquid option names on December 21st META Meta Platforms $199.69 / -2.42 (-1.20%) 03/15/23 Meta Platforms (Facebook) call buyer realizes 189% same-day gains 03/06/23 Notable open interest changes for March 6th 02/28/23 Early notable gainers among liquid option names on February 28th LAZR Luminar $6.61 / -1.12 (-14.50%) 03/10/23 Luminar Technologies put volume heavy and directionally bearish 03/03/23 Largest borrow rate increases among liquid names 02/28/23 Luminar Technologies call volume above normal and directionally bullish 02/27/23 Luminar Technologies options imply 18.5% move in share price post-earnings HSY Hershey $242.70 / -0.305 (-0.13%) 11/16/22 Early notable gainers among liquid option names on November 16th HST Host Hotels $15.07 / -0.81 (-5.10%) 12/22/22 Early notable gainers among liquid option names on December 22nd GOOGL Alphabet $103.38 / -1.53 (-1.46%) 02/27/23 Notable open interest changes for February 27th 02/15/23 Notable open interest changes for February 15th GOOG Alphabet $104.27 / -1.59 (-1.50%) 03/16/23 Alphabet call buyer realizes 17% same-day gains 02/28/23 Notable open interest changes for February 28th 02/10/23 Unusually active option classes on open February 10th 02/10/23 Notable open interest changes for February 10th GME GameStop $23.83 / +6.2 (+35.17%) 03/21/23 GameStop options imply 10.1% move in share price post-earnings 03/20/23 Largest borrow rate increases among liquid names 02/02/23 GameStop call volume above normal and directionally bullish 01/26/23 Largest borrow rate increases among liquid names DNUT Krispy Kreme $15.33 / +0.915 (+6.35%) 10/27/22 Largest borrow rate increases among liquid names 10/24/22 Largest borrow rate increases among liquid names CVNA Carvana $8.42 / +0.49 (+6.18%) 02/28/23 Largest borrow rate increases among liquid names 02/23/23 Carvana options imply 20.6% move in share price post-earnings 02/22/23 Largest borrow rate increases among liquid names 02/17/23 Carvana call volume above normal and directionally bullish BABA Alibaba $83.64 / -0.06 (-0.07%) 03/17/23 Alibaba call volume above normal and directionally bullish 02/27/23 Alibaba put buyer realizes 5% same-day gains 02/23/23 Unusually active option classes on open February 23rd 02/23/23 Notable open interest changes for February 23rd BA Boeing $196.11 / -8.595 (-4.20%) 02/24/23 Unusually active option classes on open February 24th 01/25/23 Unusually active option classes on open January 25th 01/06/23 Unusually active option classes on open January 6th 12/12/22 Boeing call volume above normal and directionally bullish ARRY Array Technologies $19.61 / +0.88 (+4.70%) 03/21/23 Array Technologies options imply 4.0% move in share price post-earnings 03/20/23 Array Technologies call volume above normal and directionally bullish 03/15/23 Array Technologies options imply 6.5% move in share price post-earnings 03/06/23 Array Technologies call volume above normal and directionally bullish ALT Altimmune $4.19 / -0.76 (-15.35%) 03/20/23 Altimmune put volume heavy and directionally bearish 03/09/23 Altimmune call volume above normal and directionally bullish 03/08/23 Altimmune call volume above normal and directionally bullish 03/03/23 Altimmune call volume above normal and directionally bullish ABBV AbbVie $153.67 / -3.155 (-2.01%) 02/09/23 Unusually active option classes on open February 9th 01/18/23 Unusually active option classes on open January 18th 10/28/22 Unusually active option classes on open October 28th SPY SPX SPY SPDR S&P 500 ETF Trust $392.13 / -6.76 (-1.69%) 03/22/23 SPDR S&P 500 ETF Trust: Pivot points 03/21/23 SPDR S&P 500 ETF Trust: Pivot points 03/20/23 SPDR S&P 500 ETF Trust: Pivot points SPX S&P 500 / + 03/22/23 Fed says 'additional policy firming may be appropriate'
On The Fly	What You Missed On Wall Street This Morning » 12:00 03/22/23 03/22 12:00 03/22/23 12:00 NKE Nike $123.67 / -1.91 (-1.52%) , ABBV AbbVie $155.92 / -0.9 (-0.57%) , PACW PacWest Bancorp $10.90 / -1.26 (-10.36%) , GME GameStop $24.95 / +7.32 (+41.52%) , ARRY Array Technologies $19.86 / +1.13 (+6.03%) , META Meta Platforms $203.95 / +1.84 (+0.91%) , SPOT Spotify $129.56 / +0.79 (+0.61%) , WMG Warner Music $31.17 / +0.6 (+1.96%) , DNUT Krispy Kreme $15.43 / +1.015 (+7.04%) , ALT Altimmune $4.29 / -0.66 (-13.33%) , LAZR Luminar $6.73 / -0.995 (-12.88%) , NVS Novartis $82.69 / -0.97 (-1.16%) , CSSE Chicken Soup for the Soul $2.59 / -0.065 (-2.45%) , BA Boeing $199.80 / -4.905 (-2.40%) , VORB Virgin Orbit / + , NSRGY Nestle $117.14 / -0.42 (-0.36%) , ETNB 89bio $14.21 / +3.275 (+29.96%) , CVNA Carvana $9.83 / +1.9 (+23.96%) , OLLI Ollie's Bargain Outlet $57.69 / +4.45 (+8.36%) , SCHW Charles Schwab $57.36 / -2.13 (-3.58%) , HST Host Hotels $15.32 / -0.56 (-3.53%) , HSY Hershey $244.25 / +1.245 (+0.51%) , WOOF Petco $8.79 / -1.36 (-13.40%) , HQY HealthEquity $58.52 / +0.195 (+0.33%) , INZY Inozyme $3.04 / +0.005 (+0.16%) , SPPI Spectrum / + Get caught up quickly on… Open Full Text ShowHide Related Items >><< Company News Street Research Earnings Syndicate Periodicals On The Fly Events Options WOOF WMG VORB SPPI SPOT SCHW PACW OLLI NVS NSRGY NKE META LAZR INZY HSY HST HQY GME ETNB DNUT CVNA CSSE BA ARRY ALT ABBV WOOF Petco $8.79 / -1.36 (-13.40%) 03/22/23 Petco falls 7% to $9.44 after Q4 results, FY23 guidance 03/22/23 Freshpet, Petco announce delivery partnership 03/22/23 Petco expects to make $100M in principal payments on term loan in FY23 03/22/23 Petco sees FY23 CapEx $225M-$250M WMG Warner Music $31.17 / +0.6 (+1.96%) 01/23/23 Warner Music acquires recorded music rights to English band Yes' catalog 12/15/22 Warner Music announces partnership with DRESSX 12/02/22 Warner Music director Benet sells 15,000 class A common shares 11/09/22 OverActive Media, Warner Music Spain extend commercial partnership agreement VORB Virgin Orbit / + 03/22/23 Virgin Orbit confirms incremental resumption of operations 03/16/23 Virgin Orbit confirms operational pause amid discussions for funding 02/14/23 Virgin Orbit provides update on U.K. mission anomaly 02/03/23 Virgin Orbit, SatRev announce follow-on launch services agreement SPPI Spectrum / + 02/08/23 CMS grants Spectrum permanent J-Code for Rolvedon injection 01/04/23 Spectrum announces that CMO Francois Lebel, M.D. steps down 12/06/22 Spectrum announces Rolvedon added to latest NCCN Guidelines 11/25/22 Spectrum receives CRL from FDA regarding NDA for poziotinib SPOT Spotify $129.56 / +0.79 (+0.61%) 03/08/23 Spotify introduces Spotify for Podcasters, offering more 'access to innovation' 01/31/23 Spotify rises 9.8% 01/31/23 Spotify reports Q4 MAUs up 20% y/y to 489M 01/26/23 Spotify tweets 'everything's looking much better now' SCHW Charles Schwab $57.36 / -2.13 (-3.58%) 03/20/23 Charles Schwab director buys $200K in common stock 03/17/23 Charles Schwab reports $16.5B in core net new assets over past five trading days 03/16/23 Charles Schwab director buys $233.5K in common stock 03/15/23 Charles Schwab director buys $2.0M in common stock PACW PacWest Bancorp $10.90 / -1.26 (-10.36%) 03/22/23 Pacific Western Bank determines not to move forward with capital raise 03/22/23 Pacific Western Bank reports $11.4B in available cash as of March 20 03/20/23 PacWest Bancorp says bank continues to have 'solid liquidity' 03/16/23 PacWest Bancorp trading resumes OLLI Ollie's Bargain Outlet $57.69 / +4.45 (+8.36%) 03/22/23 Ollie's Bargain Outlet jumps 11% to $59.00 after Q4 earnings beat and FY23 guide 10/17/22 Ollie's Bargain Outlet appoints Rob Helm as CFO NVS Novartis $82.69 / -0.97 (-1.16%) 03/21/23 Novartis alpelisib granted FDA orphan designation 03/21/23 Novartis' Sandoz receives FDA approval for biosimilar Hyrimoz HCF 03/17/23 Novartis terminates collaboration and license pact with Sangamo 03/16/23 Novartis' Tafinlar + Mekinist approved by FDA for pediatric patients NSRGY Nestle $117.14 / -0.42 (-0.36%) 02/08/23 Nestle Purina recalls select lots of dry dog food over vitamin D concerns 02/01/23 Nestle Canada announces wind down, exit of Frozen Meals & Pizza business 12/12/22 Fonterra and Nestle agree to sale of DPA Brazil joint venture 11/29/22 Nestle to explore strategic options for peanut allergy treatment NKE Nike $123.67 / -1.91 (-1.52%) 03/21/23 Nike pares afterhours gains, down 0.9% after Q4 and FY23 outlook 03/21/23 Nike jumps 4% to $131.00 after Q3 earnings beat 03/21/23 Nike reports Q3-end inventories at $8.9B, up 16% from last year 03/21/23 Nike reports Direct sales up 17% at $5.3B META Meta Platforms $203.95 / +1.84 (+0.91%) 03/21/23 Nvidia announces availability of new products featuring H100 Tensor Core GPU 03/15/23 Facebook Ireland violated law over data use, Amsterdam court ruled 03/15/23 Oportun Financial expands executive team with key new hires 03/14/23 Meta targeting summer to complete analysis from hybrid work year of learning LAZR Luminar $6.73 / -0.995 (-12.88%) 02/28/23 Luminar off earlier highs, goes red after Q4 business update at 'Luminar Day' 02/28/23 Luminar unveils new Iris+ sensor, announces Luminar AI Engine 02/28/23 Luminar partners with Swiss Re to launch insurance program 02/22/23 Luminar up 15% to $6.62 after announcing expansion of Mercedes-Benz partnership INZY Inozyme $3.04 / +0.005 (+0.16%) 03/22/23 Inozyme expects cash to fund requirements into 4Q24 03/22/23 Inozyme appoints Matthew Winton as COO 03/22/23 Inozyme CEO Axel Bolte to retire, Douglas Treco to succeed 02/16/23 Inozyme announces anticipated milestones HSY Hershey $244.25 / +1.245 (+0.51%) 02/21/23 Bath & Body Works appoints Hershey CFO Voskuil to board 12/07/22 Hershey announces first bilingual manufacturing facility 10/20/22 Hershey signs new solar power purchase agreement with National Grid Renewables HST Host Hotels $15.32 / -0.56 (-3.53%) 02/15/23 Host Hotels provides RevPAR outlook for next three quarters 02/15/23 Host Hotels provides update on Hurricane Ian damage 12/15/22 Host Hotels board authorizes special dividend of 20c per share 11/29/22 Host Hotels appoints Mari Sifo as EVP, Chief Human Resources Officer HQY HealthEquity $58.52 / +0.195 (+0.33%) 01/09/23 HealthEquity announces HSA sales outlook 09/22/22 Director of HealthEquity Sacks sells $1.8M in company shares 09/22/22 Director of HealthEquity Sacks sells $1.8M in company shares GME GameStop $24.95 / +7.32 (+41.52%) 03/22/23 GameStop rises 40.7% 03/22/23 GameStop rises 32.9% 03/22/23 GameStop rises 45.0% 03/21/23 GameStop jumps nearly 33% to over $23 after reporting Q4 profit ETNB 89bio $14.21 / +3.275 (+29.96%) 03/22/23 89bio up 47% to $16.10 after announcing positive pegozafermin trial data 03/22/23 89bio's pegozafermin trial statistically significant in critical histology 03/05/23 89bio presents new analysis of data from Phase 2 ENTRIGUE trial of pegozafermin 12/12/22 89bio announces publication of Phase 1b/2a pegozafermin study results DNUT Krispy Kreme $15.43 / +1.015 (+7.04%) 02/27/23 Krispy Kreme confirms expanded market test with McDonald's 12/15/22 Krispy Kreme down 4% amid investor day presentations 10/18/22 Krispy Kreme up 8% after reports of McDonald's testing donut sales partnership 09/26/22 Krispy Kreme offers free coffee on National Coffee Day CVNA Carvana $9.83 / +1.9 (+23.96%) 03/22/23 Carvana rises 23.6% 03/22/23 Carvana rises 16.3% 03/22/23 Carvana rises 22.8% 03/22/23 Carvana trading resumes CSSE Chicken Soup for the Soul $2.59 / -0.065 (-2.45%) 01/19/23 Chicken Soup for the Soul acquires North American rights to Devil's Peak 10/18/22 Chicken Soup teams with Publicis' APX Content Ventures on new reality series 10/13/22 Chicken Soup for the Soul says Crackle button to be added to Hisense Smart TVs 10/05/22 Chicken Soup for the Soul Entertainment appoints Phil Oppenheim CCO BA Boeing $199.80 / -4.905 (-2.40%) 03/17/23 Boeing awarded $1.95B Army contract modification 03/14/23 Boeing reports 28 commercial airplane deliveries, 5 orders in February 03/14/23 Saudi Arabian Airlines selects up to 49 Boeing 787 Dreamliners 03/14/23 Riyadh Air choses Boeing 787 Dreamliner to power its global launch ARRY Array Technologies $19.86 / +1.13 (+6.03%) 03/15/23 Array Technologies reschedules earnings, needs more time to file annual report 03/03/23 Avangrid announces intent to deploy more than $30M in solar trackers from Array 01/30/23 Array Technologies names Manning as Chief Operations Officer 11/08/22 Array Technologies appoints Jokinen to board of directors ALT Altimmune $4.29 / -0.66 (-13.33%) 03/21/23 Altimmune falls 35% to $7.15 after initerim MOMENTUM Phase 2 trial data 03/21/23 Altimmune announces reuslts from interim analysis of MOMENTUM Phase 2 trial 01/04/23 Altimmune appoints Jordt as Chief Business Officer 12/20/22 Altimmune announces topline results from 24-week trial of pemvidutide ABBV AbbVie $155.92 / -0.9 (-0.57%) 03/22/23 AbbVie receives CRL from FDA for NDA for ABBV-951 03/19/23 AbbVie announces late-breaking results for SKYRIZI study 02/27/23 AbbVie receives CHMP opinion recommending approval for upadacitinib 02/23/23 AbbVie, Capsida announce expanded genetic medicines for eye diseases pact NKE ABBV PACW GME ARRY META SPOT WMG DNUT ALT LAZR NVS CSSE BA VORB NSRGY ETNB CVNA OLLI SCHW HST HSY WOOF HQY INZY SPPI NKE Nike $123.67 / -1.91 (-1.52%) 03/22/23 BofA Nike inventory progress coming at expense of margins, says BofA 03/22/23 Evercore ISI Nike added to 'Tactical Outperform' list at Evercore ISI 03/22/23 Piper Sandler Nike price target raised to $112 from $105 at Piper Sandler 03/22/23 Jefferies Nike price target raised to $160 from $140 at Jefferies ABBV AbbVie $155.92 / -0.9 (-0.57%) 03/16/23 Chardan Immunome price target lowered to $8 from $9 at Chardan 03/01/23 Guggenheim Guggenheim starts AbbVie with a Buy on diversified growth 02/28/23 Guggenheim AbbVie initiated with a Buy at Guggenheim 02/22/23 BMO Capital AbCellera price target lowered to $32 from $40 at BMO Capital PACW PacWest Bancorp $10.90 / -1.26 (-10.36%) 03/22/23 RBC Capital PacWest provides detailed update on deposit balances, says RBC Capital 03/20/23 Piper Sandler Piper confident PacWest can make it through liquidity crunch 03/20/23 DA Davidson PacWest Bancorp price target lowered to $26 from $29 at DA Davidson 03/13/23 DA Davidson PacWest Bancorp upgraded to Buy at DA Davidson following 54% drop in stock GME GameStop $24.95 / +7.32 (+41.52%) 12/08/22 Wedbush GameStop price target lowered to $5.30 from $6 at Wedbush 10/13/22 Jefferies GameStop transferred with a Hold at Jefferies 08/16/22 B. Riley B. Riley downgrades 'meme stock' Bed Bath & Beyond to Sell 07/22/22 Wedbush GameStop price target lowered to $7.50 from $30 at Wedbush ARRY Array Technologies $19.86 / +1.13 (+6.03%) 03/22/23 Guggenheim Array Technologies price target lowered to $35 from $36 at Guggenheim 03/09/23 Citi Array Technologies initiated with a Neutral at Citi 03/07/23 Piper Sandler Array Technologies price target lowered to $26 from $28 at Piper Sandler 03/01/23 Scotiabank Array Technologies initiated with an Outperform at Scotiabank META Meta Platforms $203.95 / +1.84 (+0.91%) 03/22/23 KeyBanc Meta Platforms upgraded to Overweight from Sector Weight at KeyBanc 03/21/23 Morgan Stanley Meta Platforms upgraded to Overweight from Equal Weight at Morgan Stanley 03/20/23 Loop Capital Meta Platforms price target raised to $220 from $188 at Loop Capital 03/20/23 Edward Jones Meta Platforms upgraded to Buy from Hold at Edward Jones SPOT Spotify $129.56 / +0.79 (+0.61%) 03/22/23 Guggenheim Spotify upgraded to Buy at Guggenheim on music industry growth potential 03/22/23 Guggenheim Spotify upgraded to Buy from Neutral at Guggenheim 03/10/23 BofA Spotify price target raised to $143 from $120 at BofA 03/01/23 Redburn Spotify upgraded to Buy from Neutral at Redburn WMG Warner Music $31.17 / +0.6 (+1.96%) 03/22/23 Guggenheim Warner Music upgraded to Buy at Guggenheim on music industry growth potential 03/22/23 Guggenheim Warner Music upgraded to Buy from Neutral at Guggenheim 01/30/23 Deutsche Bank Warner Music price target raised to $43 from $37 at Deutsche Bank 01/23/23 Barclays Warner Music downgraded to Equal Weight from Overweight at Barclays DNUT Krispy Kreme $15.43 / +1.015 (+7.04%) 03/22/23 Truist Krispy Kreme upgraded to Buy at Truist on volume growth, FX tailwinds 03/22/23 Truist Krispy Kreme upgraded to Buy from Hold at Truist 02/14/23 HSBC Krispy Kreme price target lowered to $14 from $15 at HSBC 01/17/23 Morgan Stanley Krispy Kreme downgraded to Equal Weight from Overweight at Morgan Stanley ALT Altimmune $4.29 / -0.66 (-13.33%) 03/22/23 Stifel Stifel argues sympathy trading not a predictor for Viking's pending VK2735 data 03/21/23 Goldman Sachs Altimmune downgraded to Neutral from Buy at Goldman Sachs 03/21/23 William Blair William Blair says Viking bull thesis intact after Altimmune data 03/21/23 H.C. Wainwright Altimmune attractive after 'overdone' selloff, says H.C. Wainwright LAZR Luminar $6.73 / -0.995 (-12.88%) 03/21/23 Goldman Sachs Luminar downgraded to Sell from Neutral at Goldman Sachs 03/14/23 Citi Luminar price target lowered to $19 from $20 at Citi 03/06/23 JPMorgan Luminar price target raised to $20 from $15 at JPMorgan 03/01/23 Deutsche Bank Luminar price target lowered to $14 from $15 at Deutsche Bank NVS Novartis $82.69 / -0.97 (-1.16%) 01/26/23 Citi Novartis downgraded to Neutral from Buy at Citi 01/24/23 Lake Street Harrow Health price target raised to $24 from $17 at Lake Street 01/06/23 Morgan Stanley Novartis downgraded to Underweight from Equal Weight at Morgan Stanley 01/03/23 JPMorgan Novartis upgraded to Neutral from Underweight at JPMorgan CSSE Chicken Soup for the Soul $2.59 / -0.065 (-2.45%) 03/22/23 B. Riley Chicken Soup for the Soul price target lowered to $11 from $24 at B. Riley 11/15/22 Craig-Hallum Chicken Soup for the Soul price target lowered to $14 from $22 at Craig-Hallum 11/15/22 Needham Chicken Soup for the Soul price target lowered to $10 from $15 at Needham 08/12/22 DA Davidson Chicken Soup for the Soul price target raised to $52 from $40 at DA Davidson BA Boeing $199.80 / -4.905 (-2.40%) 03/22/23 Wells Fargo Boeing price target lowered to $230 from $240 at Wells Fargo 03/16/23 Northcoast Boeing initiated with a Neutral at Northcoast 03/15/23 Susquehanna Boeing February deliveries down but Q1 remain on track , says Susquehanna 03/06/23 Jefferies Boeing reconfiguration requirements 'not a new issue,' says Jefferies VORB Virgin Orbit / + 03/17/23 Canaccord Virgin Orbit rating, target put under review at Canaccord after operations halt 01/11/23 Canaccord Virgin Orbit price target lowered to $6 from $12 10/11/22 Credit Suisse Virgin Orbit initiated with Underperform on elevated cash burn at Credit Suisse 10/11/22 Credit Suisse Virgin Orbit initiated with an Underperform at Credit Suisse NSRGY Nestle $117.14 / -0.42 (-0.36%) 03/06/23 RBC Capital Nestle downgraded to Underperform from Sector Perform at RBC Capital 02/15/23 Bryan Garnier Nestle initiated with a Neutral at Bryan Garnier 01/19/23 Berenberg Nestle price target raised to CHF 130 from CHF 126 at Berenberg 01/18/23 Jefferies Nestle upgraded to Hold from Underperform at Jefferies ETNB 89bio $14.21 / +3.275 (+29.96%) 03/22/23 Raymond James Raymond James doubles 89bio price target to $50 after FGF21 'wins again' 03/22/23 Raymond James 89bio price target raised to $50 from $25 at Raymond James 03/22/23 Cantor Fitzgerald 89bio price target raised to $45 from $34 at Cantor Fitzgerald 03/22/23 Cantor Fitzgerald 89bio NASH data show high statistical significance, says Cantor Fitzgerald CVNA Carvana $9.83 / +1.9 (+23.96%) 02/27/23 Citi Carvana price target raised to $11 from $5.50 at Citi 02/24/23 Deutsche Bank Carvana price target lowered to $10 from $16 at Deutsche Bank 02/24/23 BofA Carvana price target raised to $12 from $10 at BofA 02/24/23 Wedbush Wedbush keeps $1 target on Carvana after 'awful' quarter OLLI Ollie's Bargain Outlet $57.69 / +4.45 (+8.36%) 02/28/23 Piper Sandler Ollie's Bargain Outlet price target raised to $72 from $60 at Piper Sandler 02/06/23 Wells Fargo Ollie's Bargain Outlet price target raised to $67 from $60 at Wells Fargo 12/08/22 Jefferies Ollie's Bargain Outlet price target lowered to $60 from $65 at Jefferies 12/08/22 Craig-Hallum Ollie's Bargain Outlet price target lowered to $65 from $70 at Craig-Hallum SCHW Charles Schwab $57.36 / -2.13 (-3.58%) 03/22/23 Barclays Charles Schwab price target lowered to $61 from $79 at Barclays 03/15/23 Credit Suisse Charles Schwab upgraded to Outperform from Neutral at Credit Suisse 03/14/23 JPMorgan Schwab funding concerns 'significantly de-risked,' says JPMorgan 03/14/23 Piper Sandler Charles Schwab price target lowered to $95 from $100 at Piper Sandler HST Host Hotels $15.32 / -0.56 (-3.53%) 03/22/23 Compass Point Host Hotels downgraded to Neutral from Buy at Compass Point 02/16/23 Stifel Host Hotels price target lowered to $21 from $22 at Stifel 01/09/23 Jefferies Hilton downgraded to Hold from Buy at Jefferies 01/09/23 Jefferies Marriott downgraded to Hold from Buy at Jefferies HSY Hershey $244.25 / +1.245 (+0.51%) 03/20/23 Deutsche Bank Hershey price target lowered to $237 from $246 at Deutsche Bank 03/17/23 Erste Group Hershey upgraded to Buy from Hold at Erste Group 02/02/23 Goldman Sachs Hershey price target raised to $277 from $255 at Goldman Sachs 01/06/23 Evercore ISI Hershey downgraded to In Line from Outperform at Evercore ISI WOOF Petco $8.79 / -1.36 (-13.40%) 03/15/23 Wedbush Petco price target lowered to $12 from $17 at Wedbush 03/13/23 Citi Citi downgrades Petco into results on weakening consumer 03/13/23 Citi Petco downgraded to Neutral from Buy at Citi 12/01/22 RBC Capital Petco price target lowered to $16 from $17 at RBC Capital HQY HealthEquity $58.52 / +0.195 (+0.33%) 02/03/23 Wells Fargo HealthEquity price target lowered to $89 from $101 at Wells Fargo 01/24/23 Deutsche Bank HealthEquity price target raised to $72 from $68 at Deutsche Bank 01/03/23 BTIG Sharecare named Top Pick for first half of 2023 at BTIG 12/16/22 Baird HealthEquity bullish Fresh Pick designation extended at Baird INZY Inozyme $3.04 / +0.005 (+0.16%) 07/19/22 Piper Sandler Promising Inozyme results offer meaningful upside for stock, says Piper Sandler 05/26/22 Jefferies Inozyme initiated with a Hold at Jefferies 04/14/22 Piper Sandler Investors should take close look at Inozyme, says Piper Sandler 04/04/22 Piper Sandler Piper likes Inozyme shares up to $40 after 'promising' update SPPI Spectrum / + 01/31/23 H.C. Wainwright Spectrum Q4 sales dramatically beat estimates, says H.C. Wainwright 11/25/22 H.C. Wainwright Spectrum price target lowered to $4 from $6 at H.C. Wainwright 11/16/22 B. Riley Spectrum downgraded to Neutral from Buy at B. Riley 09/23/22 H.C. Wainwright Spectrum price target lowered to $6 from $9 at H.C. Wainwright WOOF WMG SPPI SPOT SCHW PACW OLLI NVS NSRGY NKE META LAZR INZY HSY HST HQY GME ETNB DNUT CVNA CSSE BA ARRY ALT ABBV WOOF Petco $8.79 / -1.36 (-13.40%) 03/22/23 Petco sees FY23 revenue $6.15B-$6.275B, consensus $6.36B 03/22/23 Petco reports Q4 adjusted EPS 23c, consensus 24c WMG Warner Music $31.17 / +0.6 (+1.96%) 02/09/23 Warner Music reports Q1 EPS 23c, consensus 26c 11/22/22 Warner Music reports Q4 EPS 28c, consensus 13c SPPI Spectrum / + 03/22/23 Spectrum reports Q4 EPS (5c), consensus (11c) 01/31/23 Spectrum rallies after preliminary Q4 sales crush estimates 11/10/22 Spectrum reports Q3 EPS (12c), consensus (15c) SPOT Spotify $129.56 / +0.79 (+0.61%) 01/31/23 Spotify sees Q1 revenue EUR 3.1B, gross margin 24.9% 01/31/23 Spotify reports Q4 EPS (EUR 1.40) vs. (EUR 0.20) last year 10/25/22 Spotify reports Q3 Operating loss EUR (228M) vs. profit EUR 75M prior SCHW Charles Schwab $57.36 / -2.13 (-3.58%) 01/18/23 Charles Schwab reports Q4 adjusted EPS $1.07, consensus $1.09 01/17/23 Notable companies reporting before tomorrow's open 10/27/22 Charles Schwab backs 11%-13% year-over-year revenue growth outlook PACW PacWest Bancorp $10.90 / -1.26 (-10.36%) 01/26/23 PacWest Bancorp reports Q4 EPS 33c, consensus 97c 10/19/22 PacWest Bancorp reports Q3 EPS 1.02, consensus $1.07 OLLI Ollie's Bargain Outlet $57.69 / +4.45 (+8.36%) 03/22/23 Ollie's Bargain Outlet sees 2023 adjusted EPS $2.49-$2.58, consensus $2.38 03/22/23 Ollie's Bargain Outlet reports Q4 adjusted EPS 84c, consenus 79c 03/21/23 Notable companies reporting before tomorrow's open NVS Novartis $82.69 / -0.97 (-1.16%) 02/01/23 Novartis sees core operating income to grow mid single digit percentage in 2023 02/01/23 Novartis reports Q4 core EPS $1.52, consensus $1.44 10/25/22 Novartis confirms mid single digit sales, core operating income guidance 10/25/22 Novartis reports Q3 core EPS $1.58 vs. $1.71 last year NSRGY Nestle $117.14 / -0.42 (-0.36%) 02/16/23 Nestle confirms 2025 targets 02/16/23 Nestle sees FY23 organic sales growth 6%-8% 02/16/23 Nestle reports FY22 sales CHF 94.42B vs. CHF 87.09B last year 11/29/22 Nestle sees constant currency earnings growth of 6%-10% through 2025 NKE Nike $123.67 / -1.91 (-1.52%) 03/21/23 Nike sees FY23 revenue up high single digits, gross margins down 250bps 03/21/23 Nike reports Q3 EPS 79c, consensus 55c 03/21/23 Notable companies reporting after market close 12/20/22 Nike sees FY23 revenue growth in mid teens, consensus $49.01B META Meta Platforms $203.95 / +1.84 (+0.91%) 02/01/23 Meta Platforms sees Q1 revenue $26B-$28.5B, consensus $27.14B 02/01/23 Meta Platforms reports Q4 EPS $1.76, consensus $2.22 02/01/23 Notable companies reporting after market close 11/09/22 Meta Platforms backs Q4 revenue outlook $30B-$32.5B, consensus $31.52B LAZR Luminar $6.73 / -0.995 (-12.88%) 02/28/23 Luminar sees FY23 revenue growth of 'at least 100%,' consensus $116.14M 02/28/23 Luminar reports Q4 EPS (26c), consensus (21c) 11/02/22 Luminar reports Q3 EPS (18c), consensus (20c) 11/02/22 Notable companies reporting after market close INZY Inozyme $3.04 / +0.005 (+0.16%) 03/22/23 Inozyme reports 2022 EPS ($1.78), consensus ($1.81) 11/10/22 Inozyme reports Q3 EPS (38c), consensus (43c) HSY Hershey $244.25 / +1.245 (+0.51%) 03/22/23 Hershey backs FY23 adjusted EPS growth view 9%-11%, consensus $9.35 02/02/23 Hershey sees FY23 adjusted EPS up 9%-11%, consensus $8.94 02/02/23 Hershey reports Q4 adjusted EPS $2.02, consensus $1.77 02/01/23 Notable companies reporting before tomorrow's open HST Host Hotels $15.32 / -0.56 (-3.53%) 02/15/23 Host Hotels reports Q4 EPS 20c, consensus 19c 11/02/22 Host Hotels reports Q3 EPS 16c, consensus 17c HQY HealthEquity $58.52 / +0.195 (+0.33%) 03/21/23 HealthEquity sees FY24 EPS $1.74-$1.87, consensus $1.76 03/21/23 HealthEquity reports Q4 EPS 0c, consensus 35c 12/06/22 HealthEquity sees FY24 revenue $950M-$970M, consensus $948.4M 12/06/22 HealthEquity raises FY23 EPS view to $1.26-$1.35 from $1.23-$1.32 GME GameStop $24.95 / +7.32 (+41.52%) 03/21/23 GameStop reports Q4 EPS 16c, consensus (13c) 12/07/22 GameStop reports Q3 EPS (31c), consensus (28c) ETNB 89bio $14.21 / +3.275 (+29.96%) 03/10/23 89bio reports Q4 EPS (48c), consensus (69c) 11/10/22 89bio reports Q3 EPS (57c), consensus (80c) DNUT Krispy Kreme $15.43 / +1.015 (+7.04%) 02/15/23 Krispy Kreme sees FY23 adjusted EPS 31c-34c, consensus 36c 02/15/23 Krispy Kreme reports Q4 adjusted EPS 11c, consensus 10c 12/15/22 Krispy Kreme sees FY26 revenue about $2.15B, adjusted EPS about 53c 12/15/22 Krispy Kreme sees FY23 revenue up low double digits in constant currency CVNA Carvana $9.83 / +1.9 (+23.96%) 03/22/23 Carvana sees Q1 revenue $2.4B-$2.6B, consensus $2.7B 02/23/23 Carvana reports Q4 EPS ($7.61) vs ($1.02) last year 02/23/23 Notable companies reporting after market close 11/03/22 Carvana sees sequential reduction in retail units sold in Q4 CSSE Chicken Soup for the Soul $2.59 / -0.065 (-2.45%) 11/14/22 Chicken Soup for the Soul reports Q3 EPS ($1.13), consensus ($1.18) BA Boeing $199.80 / -4.905 (-2.40%) 01/25/23 Boeing reports Q4 core EPS ($1.75), consensus 26c 01/24/23 Notable companies reporting before tomorrow's open 10/26/22 Boeing reports Q3 core EPS ($6.18), consensus 2c ARRY Array Technologies $19.86 / +1.13 (+6.03%) 03/21/23 Array Technologies sees FY23 adjusted EPS 75c-85c, consensus 78c 03/21/23 Array Technologies reports Q4 adjusted EPS 10c, consensus 8c 03/02/23 Array Technologies sees 2023 adjusted EPS 75c-85c, consensus 95c ALT Altimmune $4.29 / -0.66 (-13.33%) 02/28/23 Altimmune reports Q4 EPS (43c), consensus (50c) 11/10/22 Altimmune reports Q3 EPS (48c), consensus (50c) ABBV AbbVie $155.92 / -0.9 (-0.57%) 02/09/23 AbbVie sees Q1 adjusted EPS $2.39-$2.49, consensus $3.08 02/09/23 AbbVie sees FY23 revenue about $52B, consensus $54.21B 02/09/23 AbbVie sees FY23 adjusted EPS $10.70-$11.10, consensus $11.65 02/09/23 AbbVie reports Q4 adjusted EPS $3.60, consensus $3.56 10 Mar 02 Aug 29 Jun 22 Apr WMG VORB SPOT SCHW PACW NVS NSRGY NKE META LAZR HSY GME DNUT CVNA CSSE BA ARRY ABBV WMG Warner Music $31.17 / +0.6 (+1.96%) 11/09/22 Record labels ask TikTok for increased ad revenue, royalties, Bloomberg reports VORB Virgin Orbit / + 03/22/23 Virgin Orbit returning 'small' team to work Thursday, CNBC reports 03/22/23 Virgin Orbit nearing deal for $200M investment from Matthew Brown, Reuters says 03/16/23 Virgin Orbit in discussions over possible buyout, FT reports 03/15/23 Virgin Orbit pauses operations for a week amid funding crunch, CNBC says SPOT Spotify $129.56 / +0.79 (+0.61%) 03/15/23 Spotify's Soderstrom says HiFi still 'coming at some point,' The Verge reports 03/08/23 Spotify narrows its focus in podcasting business, Verge says 02/28/23 EU narrows Apple probe to app restrictions, FT reports 02/10/23 ValueAct takes stake in Spotify, Bloomberg reports SCHW Charles Schwab $57.36 / -2.13 (-3.58%) 03/14/23 Ron Baron told CNBC bought Charles Schwab shares yesterday 02/27/23 Schwab to face suit seeking to unwind TD Ameritrade deal, Bloomberg says 01/07/23 Charles Schwab stock ready to put 2022 behind it, time to buy, Barron's says 12/10/22 Microsoft, Arista among stocks that can survive a triple whammy, Barron's says PACW PacWest Bancorp $10.90 / -1.26 (-10.36%) 03/16/23 PacWest in talks for liquidity boost, Reuters says 03/16/23 PacWest in talks for liquidity boost from Atlas SP Partners, Reuters says NVS Novartis $82.69 / -0.97 (-1.16%) 03/22/23 Novartis halts Leqvio heart attack prevention trial, Reuters reports 02/08/23 Avrobio exploring potential sale after approach, Street Insider says 12/29/22 Novartis to pay $245M to settle lawsuit on Exforge medicine, Bloomberg reports 11/16/22 Novartis exploring sale of ophthalmology, respiratory units, Bloomberg says NSRGY Nestle $117.14 / -0.42 (-0.36%) 03/22/23 Nestle says most of its main portfolio is ranked as unhealthy, WSJ reports 02/16/23 Nestle intends to raise prices as inflation hurts profits, CNBC says 02/05/23 CEO says Nestle to hike food prices further this year, Reuters reports 12/19/22 Hershey among brands called out by Consumer Reports for lead exposure NKE Nike $123.67 / -1.91 (-1.52%) 12/05/22 Nike cut ties with Kyrie Irving, The Athletic reports 11/25/22 Brookfield acquired Nike label supplier Trimco Group, Bloomberg reports 11/15/22 Nike to open online store for virtual sneakers, Bloomberg reports 10/15/22 Shortages have turned to gluts, off-price retailers could benefit, Barron's says META Meta Platforms $203.95 / +1.84 (+0.91%) 03/21/23 TikTok reassures advertisers over U.S. ban threat, WSJ reports 03/20/23 TikTok to tell Congress it has 150M monthly active U.S. users, Reuters reports 03/19/23 Meta rolling out verified subscription service in U.S., WSJ reports 03/17/23 DOJ investigating ByteDance for surveillance of American citizens, NY Times says LAZR Luminar $6.73 / -0.995 (-12.88%) 03/20/23 Luminar accused of passing off next-gen chip design of rival as own, Forbes says 01/06/23 Luminar falls after Citron sees shares heading below $1 01/06/23 Luminar shares heading to under $1, Citron Research says 10/01/22 SPAC bubble has burst, Blue Owl Luminar still have potential, Barron's says HSY Hershey $244.25 / +1.245 (+0.51%) 12/30/22 Hershey sued over metals content in dark chocolate, Reuters says GME GameStop $24.95 / +7.32 (+41.52%) 02/02/23 Ryan Cohen amasses sizable stake in Nordstrom, WSJ reports 01/18/23 Video game sales fell 13% y/y in Europe in December, GI.biz says 01/16/23 Activist investor Ryan Cohen builds stake in Alibaba, WSJ reports 12/05/22 GameStop starts round of layoffs, Axios reports DNUT Krispy Kreme $15.43 / +1.015 (+7.04%) 02/27/23 McDonald's expanding test with Krispy Kreme to over 150 restaurants, CNBC says 10/18/22 McDonald's to sell Krispy Kreme doughnuts, Restaurant Business reports CVNA Carvana $9.83 / +1.9 (+23.96%) 03/22/23 Carvana looking to restructure $9B debt load, FT reports 01/30/23 Carvana, CarMax pressured by 'abrupt end' to pandemic used-car boom, NYT says 01/13/23 Carvana further cutting staff amid deeper sales slowdown, WSJ says 12/07/22 Carvana talking to Kirkland, Moelis about restructuring debt, Bloomberg says CSSE Chicken Soup for the Soul $2.59 / -0.065 (-2.45%) 03/22/23 Chicken Soup for the Soul tightens belt, but not planning layoffs, Deadline says 09/24/22 Chicken Soup for the Soul a cheap way to play the future of TV, Barron's says BA Boeing $199.80 / -4.905 (-2.40%) 03/22/23 Boeing to take charges on KC-46 tanker amid quality issue, Reuters reports 03/17/23 Netflix, Boeing involved in U.S. business mission to Vietnam, Reuters says 03/16/23 Boeing resumes deliveries of 787 Dreamliner, Reuters reports 03/14/23 Amazon targets 2024 launch of first Kuiper internet satellites, Reuters reports ARRY Array Technologies $19.86 / +1.13 (+6.03%) 12/02/22 Chinese solar producers dodged U.S. tariffs, WSJ reports ABBV AbbVie $155.92 / -0.9 (-0.57%) 02/06/23 AbbVie looking for next hit drug after competitors target Humira, WSJ reports 01/31/23 AbbVie's Humira drug faces competition in the U.S., FT reports 12/03/22 Buy AbbVie, stock still worth owning even as Humira fades, Barron's says 11/16/22 Optum Rx puts biosimilars on formulary against AbbVie's Humira, Bloomberg says WOOF WMG VORB SPPI SPOT SCHW PACW OLLI NVS NKE META HSY HQY GME ETNB DNUT CVNA BA ARRY ALT ABBV WOOF Petco $8.79 / -1.36 (-13.40%) 11/30/22 What You Missed On Wall Street On Wednesday 11/30/22 What You Missed On Wall Street This Morning 11/30/22 Fly Intel: Pre-market Movers WMG Warner Music $31.17 / +0.6 (+1.96%) 01/13/23 What You Missed On Wall Street On Friday 01/13/23 What You Missed On Wall Street This Morning 01/13/23 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 11/23/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations VORB Virgin Orbit / + 01/10/23 Fly Intel: Pre-market Movers 11/23/22 Fly Intel: After-Hours Movers SPPI Spectrum / + 11/25/22 What You Missed On Wall Street On Friday SPOT Spotify $129.56 / +0.79 (+0.61%) 03/01/23 What You Missed On Wall Street On Wednesday 03/01/23 What You Missed On Wall Street This Morning SCHW Charles Schwab $57.36 / -2.13 (-3.58%) 03/20/23 Fly Insider: Southwest Gas, Pathward among week's notable insider trades 03/15/23 What You Missed On Wall Street On Wednesday 03/15/23 What You Missed On Wall Street This Morning 03/15/23 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations PACW PacWest Bancorp $10.90 / -1.26 (-10.36%) 03/20/23 What You Missed On Wall Street On Monday 03/20/23 What You Missed On Wall Street This Morning 03/14/23 What You Missed On Wall Street On Tuesday 03/14/23 What You Missed On Wall Street This Morning OLLI Ollie's Bargain Outlet $57.69 / +4.45 (+8.36%) 12/07/22 What You Missed On Wall Street On Wednesday 12/07/22 What You Missed On Wall Street This Morning 12/07/22 Fly Intel: Pre-market Movers NVS Novartis $82.69 / -0.97 (-1.16%) 02/10/23 Biotech Alert: Searches spiking for these stocks today 02/01/23 What You Missed On Wall Street This Morning 01/12/23 Meet ZyVersa: Fly exclusive interview with CEO Stephen Glover 12/12/22 Biotech Alert: Searches spiking for these stocks today NKE Nike $123.67 / -1.91 (-1.52%) 03/22/23 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 03/22/23 Fly Intel: Pre-market Movers 03/21/23 Fly Intel: After-Hours Movers 03/21/23 Here's what Wall Street experts are saying about Nike ahead of earnings META Meta Platforms $203.95 / +1.84 (+0.91%) 03/21/23 What You Missed On Wall Street On Tuesday 03/21/23 What You Missed On Wall Street This Morning 03/21/23 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations HSY Hershey $244.25 / +1.245 (+0.51%) 02/02/23 What You Missed On Wall Street On Thursday 02/02/23 What You Missed On Wall Street This Morning 02/02/23 Fly Intel: Pre-market Movers 01/07/23 Buy/Sell: Wall Street's top 10 stock calls this week HQY HealthEquity $58.52 / +0.195 (+0.33%) 12/19/22 Fly Insider: Willdan Group, Medtronic among weeks' notable insider transactions 12/06/22 Fly Intel: After-Hours Movers GME GameStop $24.95 / +7.32 (+41.52%) 02/07/23 What You Missed This Week in Video Games 12/23/22 Sell these stocks now, proven algorithm says ETNB 89bio $14.21 / +3.275 (+29.96%) 12/19/22 Trial success is rocketing this NASH stock higher and sinking these peers DNUT Krispy Kreme $15.43 / +1.015 (+7.04%) 02/27/23 What You Missed On Wall Street On Monday 02/27/23 What You Missed On Wall Street This Morning 11/15/22 Fly Intel: Pre-market Movers CVNA Carvana $9.83 / +1.9 (+23.96%) 02/23/23 Fly Intel: After-Hours Movers 01/17/23 What You Missed On Wall Street On Tuesday 01/17/23 What You Missed On Wall Street This Morning BA Boeing $199.80 / -4.905 (-2.40%) 03/10/23 What You Missed On Wall Street On Friday 02/24/23 What You Missed On Wall Street On Friday ARRY Array Technologies $19.86 / +1.13 (+6.03%) 03/16/23 What You Missed On Wall Street On Thursday 03/16/23 What You Missed On Wall Street This Morning 03/13/23 What You Missed This Week in EVs and Clean Energy ALT Altimmune $4.29 / -0.66 (-13.33%) 12/20/22 Fly Intel: Pre-market Movers ABBV AbbVie $155.92 / -0.9 (-0.57%) 03/01/23 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 02/22/23 What You Missed On Wall Street On Wednesday 02/22/23 What You Missed On Wall Street This Morning 02/22/23 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 03/21/23 Global Industrials Conference 03/28/23 Shop Talk 04/24/23 RSA Conference 2023 05/12/23 2023 Real Estate Summit 03/22/23 Petco - WOOF 03/22/23 Ollie's Bargain Outlet - OLLI 03/22/23 Spectrum - SPPI 05/04/23 Host Hotels - HST 05/21/23 PDUFA Date for Epcoritamab (DuoBody-CD3xCD20) 04/18/23 Boeing Co. 05/01/23 Carvana Co. 05/05/23 AbbVie Inc. 05/16/23 The Hershey Company SPPI SPOT SCHW PACW NVS NKE META LAZR HSY HST GME DNUT CVNA BA ARRY ALT ABBV SPPI Spectrum / + 03/21/23 Spectrum options imply 25.8% move in share price post-earnings SPOT Spotify $129.56 / +0.79 (+0.61%) 03/06/23 Unusually active option classes on open March 6th 02/10/23 Spotify call volume above normal and directionally bullish 01/31/23 Unusually active option classes on open January 31st 01/23/23 Unusually active option classes on open January 23rd SCHW Charles Schwab $57.36 / -2.13 (-3.58%) 03/16/23 Notable open interest changes for March 16th 03/14/23 Early notable gainers among liquid option names on March 14th PACW PacWest Bancorp $10.90 / -1.26 (-10.36%) 03/20/23 Unusually active option classes on open March 20th 03/17/23 PacWest Bancorp call volume above normal and directionally bullish 03/17/23 Unusually active option classes on open March 17th 03/16/23 Unusually active option classes on open March 16th NVS Novartis $82.69 / -0.97 (-1.16%) 01/09/23 Novartis call volume above normal and directionally bullish 12/16/22 Novartis call volume above normal and directionally bullish 10/06/22 Novartis put volume heavy and directionally bearish NKE Nike $123.67 / -1.91 (-1.52%) 03/21/23 Nike options imply 7.4% move in share price post-earnings 03/21/23 Unusually active option classes on open March 21st 12/22/22 Unusually active option classes on open December 22nd 12/21/22 Early notable gainers among liquid option names on December 21st META Meta Platforms $203.95 / +1.84 (+0.91%) 03/15/23 Meta Platforms (Facebook) call buyer realizes 189% same-day gains 03/06/23 Notable open interest changes for March 6th 02/28/23 Early notable gainers among liquid option names on February 28th LAZR Luminar $6.73 / -0.995 (-12.88%) 03/10/23 Luminar Technologies put volume heavy and directionally bearish 03/03/23 Largest borrow rate increases among liquid names 02/28/23 Luminar Technologies call volume above normal and directionally bullish 02/27/23 Luminar Technologies options imply 18.5% move in share price post-earnings HSY Hershey $244.25 / +1.245 (+0.51%) 11/16/22 Early notable gainers among liquid option names on November 16th HST Host Hotels $15.32 / -0.56 (-3.53%) 12/22/22 Early notable gainers among liquid option names on December 22nd GME GameStop $24.95 / +7.32 (+41.52%) 03/21/23 GameStop options imply 10.1% move in share price post-earnings 03/20/23 Largest borrow rate increases among liquid names 02/02/23 GameStop call volume above normal and directionally bullish 01/26/23 Largest borrow rate increases among liquid names DNUT Krispy Kreme $15.43 / +1.015 (+7.04%) 10/27/22 Largest borrow rate increases among liquid names 10/24/22 Largest borrow rate increases among liquid names CVNA Carvana $9.83 / +1.9 (+23.96%) 02/28/23 Largest borrow rate increases among liquid names 02/23/23 Carvana options imply 20.6% move in share price post-earnings 02/22/23 Largest borrow rate increases among liquid names 02/17/23 Carvana call volume above normal and directionally bullish BA Boeing $199.80 / -4.905 (-2.40%) 02/24/23 Unusually active option classes on open February 24th 01/25/23 Unusually active option classes on open January 25th 01/06/23 Unusually active option classes on open January 6th 12/12/22 Boeing call volume above normal and directionally bullish ARRY Array Technologies $19.86 / +1.13 (+6.03%) 03/21/23 Array Technologies options imply 4.0% move in share price post-earnings 03/20/23 Array Technologies call volume above normal and directionally bullish 03/15/23 Array Technologies options imply 6.5% move in share price post-earnings 03/06/23 Array Technologies call volume above normal and directionally bullish ALT Altimmune $4.29 / -0.66 (-13.33%) 03/20/23 Altimmune put volume heavy and directionally bearish 03/09/23 Altimmune call volume above normal and directionally bullish 03/08/23 Altimmune call volume above normal and directionally bullish 03/03/23 Altimmune call volume above normal and directionally bullish ABBV AbbVie $155.92 / -0.9 (-0.57%) 02/09/23 Unusually active option classes on open February 9th 01/18/23 Unusually active option classes on open January 18th 10/28/22 Unusually active option classes on open October 28th
Hot Stocks	AbbVie receives CRL from FDA for NDA for ABBV-951 » 08:46 03/22/23 03/22 08:46 03/22/23 08:46 ABBV AbbVie $156.82 / +0.69 (+0.44%) AbbVie announced it… AbbVie announced it received a Complete Response Letter from the U.S. FDA for the New Drug Application for ABBV-951 for the treatment of motor fluctuations in adults with advanced Parkinson's disease. In its letter, the FDA requested additional information about the device (pump) as part of the NDA review. The CRL does not request that AbbVie conduct additional efficacy and safety trials related to the drug. AbbVie plans to resubmit the NDA as soon as possible. "There is an unmet need for people living with advanced Parkinson's disease as they face daily challenges in managing their condition," said Thomas Hudson, M.D., senior vice president, research and development, chief scientific officer, AbbVie. "We will continue to work closely with the FDA as part of our commitment to bringing this treatment option to people impacted by this disease as quickly as possible." ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options ABBV AbbVie $156.82 / +0.69 (+0.44%) 03/19/23 AbbVie announces late-breaking results for SKYRIZI study 02/27/23 AbbVie receives CHMP opinion recommending approval for upadacitinib 02/23/23 AbbVie, Capsida announce expanded genetic medicines for eye diseases pact 02/09/23 AbbVie says 'high level of confidence' in achieving FY23 guidance ABBV AbbVie $156.82 / +0.69 (+0.44%) 03/16/23 Chardan Immunome price target lowered to $8 from $9 at Chardan 03/01/23 Guggenheim Guggenheim starts AbbVie with a Buy on diversified growth 02/28/23 Guggenheim AbbVie initiated with a Buy at Guggenheim 02/22/23 BMO Capital AbCellera price target lowered to $32 from $40 at BMO Capital ABBV AbbVie $156.82 / +0.69 (+0.44%) 02/09/23 AbbVie sees Q1 adjusted EPS $2.39-$2.49, consensus $3.08 02/09/23 AbbVie sees FY23 revenue about $52B, consensus $54.21B 02/09/23 AbbVie sees FY23 adjusted EPS $10.70-$11.10, consensus $11.65 02/09/23 AbbVie reports Q4 adjusted EPS $3.60, consensus $3.56 ABBV AbbVie $156.82 / +0.69 (+0.44%) 02/06/23 AbbVie looking for next hit drug after competitors target Humira, WSJ reports 01/31/23 AbbVie's Humira drug faces competition in the U.S., FT reports 12/03/22 Buy AbbVie, stock still worth owning even as Humira fades, Barron's says 11/16/22 Optum Rx puts biosimilars on formulary against AbbVie's Humira, Bloomberg says ABBV AbbVie $156.82 / +0.69 (+0.44%) 03/01/23 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 02/22/23 What You Missed On Wall Street On Wednesday 02/22/23 What You Missed On Wall Street This Morning 02/22/23 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 05/21/23 PDUFA Date for Epcoritamab (DuoBody-CD3xCD20) 05/05/23 AbbVie Inc. ABBV AbbVie $156.82 / +0.69 (+0.44%) 02/09/23 Unusually active option classes on open February 9th 01/18/23 Unusually active option classes on open January 18th 10/28/22 Unusually active option classes on open October 28th

Sunday
Hot Stocks	AbbVie announces late-breaking results for SKYRIZI study » 15:39 03/19/23 03/19 15:39 03/19/23 15:39 ABBV AbbVie $154.22 / -1.1601 (-0.75%) AbbVie announced new… AbbVie announced new 52-week data from an open-label, single-arm study demonstrating improved plaque psoriasis signs and symptoms among a difficult-to-treat patient population who received SKYRIZI, an IL-23 inhibitor. These moderate to severe plaque psoriasis patients previously had a suboptimal response to treatment with secukinumab or ixekizumab, both IL-17A inhibitor therapies, for at least six months before switching to risankizumab. The data were presented at a Late-Breaking Research session during the 2023 American Academy of Dermatology Annual Meeting in New Orleans, Louisiana. Findings from this phase 3b, open-label single-arm study showed that 56.3% of patients who received risankizumab, without a washout period following a suboptimal response to secukinumab or ixekizumab achieved the week 16 primary endpoint of reduced signs and symptoms of psoriasis. A suboptimal response was defined as a static Physician's Global Assessment score of 2 or 3 and body surface area of 3% to less than10% after at least six months of treatment with secukinumab or ixekizumab. The mean duration of treatment was 2.6 years for patients receiving secukinumab, and 2.1 years for patients receiving ixekizumab. Highlights from this new aIMM 52-week analysis include: The majority of patients achieved clear or almost clear skin at the week 52 primary endpoint; Patients achieved completely clear skin at week 16 and week 52, a secondary endpoint; Patients reported no symptoms such as pain, itching, redness and burning, as shown by a Psoriasis Symptom Scale score of 0 at week 16 and week 52, a secondary endpoint; No new safety signals were observed in this analysis. ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options ABBV AbbVie $154.22 / -1.1601 (-0.75%) 02/27/23 AbbVie receives CHMP opinion recommending approval for upadacitinib 02/23/23 AbbVie, Capsida announce expanded genetic medicines for eye diseases pact 02/09/23 AbbVie says 'high level of confidence' in achieving FY23 guidance 02/09/23 AbbVie expects inflation to weigh on aesthetics business in 2023 ABBV AbbVie $154.22 / -1.1601 (-0.75%) 03/16/23 Chardan Immunome price target lowered to $8 from $9 at Chardan 03/01/23 Guggenheim Guggenheim starts AbbVie with a Buy on diversified growth 02/28/23 Guggenheim AbbVie initiated with a Buy at Guggenheim 02/22/23 BMO Capital AbCellera price target lowered to $32 from $40 at BMO Capital ABBV AbbVie $154.22 / -1.1601 (-0.75%) 02/09/23 AbbVie sees Q1 adjusted EPS $2.39-$2.49, consensus $3.08 02/09/23 AbbVie sees FY23 revenue about $52B, consensus $54.21B 02/09/23 AbbVie sees FY23 adjusted EPS $10.70-$11.10, consensus $11.65 02/09/23 AbbVie reports Q4 adjusted EPS $3.60, consensus $3.56 ABBV AbbVie $154.22 / -1.1601 (-0.75%) 02/06/23 AbbVie looking for next hit drug after competitors target Humira, WSJ reports 01/31/23 AbbVie's Humira drug faces competition in the U.S., FT reports 12/03/22 Buy AbbVie, stock still worth owning even as Humira fades, Barron's says 11/16/22 Optum Rx puts biosimilars on formulary against AbbVie's Humira, Bloomberg says ABBV AbbVie $154.22 / -1.1601 (-0.75%) 03/01/23 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 02/22/23 What You Missed On Wall Street On Wednesday 02/22/23 What You Missed On Wall Street This Morning 02/22/23 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 05/21/23 PDUFA Date for Epcoritamab (DuoBody-CD3xCD20) ABBV AbbVie $154.22 / -1.1601 (-0.75%) 02/09/23 Unusually active option classes on open February 9th 01/18/23 Unusually active option classes on open January 18th 10/28/22 Unusually active option classes on open October 28th

Over a week ago
Recommendations	Immunome price target lowered to $8 from $9 at Chardan » 19:58 03/16/23 03/16 19:58 03/16/23 19:58 IMNM Immunome $5.09 / +0.34 (+7.16%) , ABBV AbbVie $155.38 / +1.315 (+0.85%) Chardan analyst Matthew… Chardan analyst Matthew Barcus lowered the firm's price target on Immunome (IMNM) to $8 from $9 but keeps a Buy rating on the shares. The company's collaboration and option agreement with AbbVie (ABBV) not only provides external validation of the company's discovery platform, but also provides important non-dilutive financing for the company, which ended 2022 with $20.3M in cash and cash equivalents, the analyst tells investors in a research note. ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options IMNM ABBV IMNM Immunome $5.09 / +0.34 (+7.16%) 01/06/23 AbbVie, Immunome enter collaboration to discover novel antibody-target pairs 01/06/23 AbbVie, Immunome announce strategic collaboration 11/09/22 Immunome presents preclinical data on IMM20059 ABBV AbbVie $155.38 / +1.315 (+0.85%) 02/27/23 AbbVie receives CHMP opinion recommending approval for upadacitinib 02/23/23 AbbVie, Capsida announce expanded genetic medicines for eye diseases pact 02/09/23 AbbVie says 'high level of confidence' in achieving FY23 guidance 02/09/23 AbbVie expects inflation to weigh on aesthetics business in 2023 IMNM ABBV IMNM Immunome $5.09 / +0.34 (+7.16%) 05/13/22 Chardan Immunome price target lowered to $9 from $16 at Chardan 03/30/22 Chardan Immunome price target lowered to $16 from $21 at Chardan ABBV AbbVie $155.38 / +1.315 (+0.85%) 03/01/23 Guggenheim Guggenheim starts AbbVie with a Buy on diversified growth 02/28/23 Guggenheim AbbVie initiated with a Buy at Guggenheim 02/22/23 BMO Capital AbCellera price target lowered to $32 from $40 at BMO Capital 02/22/23 Wolfe Research AbbVie downgraded to Peer Perform on valuation at Wolfe Research ABBV ABBV AbbVie $155.38 / +1.315 (+0.85%) 02/09/23 AbbVie sees Q1 adjusted EPS $2.39-$2.49, consensus $3.08 02/09/23 AbbVie sees FY23 revenue about $52B, consensus $54.21B 02/09/23 AbbVie sees FY23 adjusted EPS $10.70-$11.10, consensus $11.65 02/09/23 AbbVie reports Q4 adjusted EPS $3.60, consensus $3.56 ABBV ABBV AbbVie $155.38 / +1.315 (+0.85%) 02/06/23 AbbVie looking for next hit drug after competitors target Humira, WSJ reports 01/31/23 AbbVie's Humira drug faces competition in the U.S., FT reports 12/03/22 Buy AbbVie, stock still worth owning even as Humira fades, Barron's says 11/16/22 Optum Rx puts biosimilars on formulary against AbbVie's Humira, Bloomberg says ABBV ABBV AbbVie $155.38 / +1.315 (+0.85%) 03/01/23 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 02/22/23 What You Missed On Wall Street On Wednesday 02/22/23 What You Missed On Wall Street This Morning 02/22/23 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 05/21/23 PDUFA Date for Epcoritamab (DuoBody-CD3xCD20) ABBV ABBV AbbVie $155.38 / +1.315 (+0.85%) 02/09/23 Unusually active option classes on open February 9th 01/18/23 Unusually active option classes on open January 18th 10/28/22 Unusually active option classes on open October 28th
On The Fly	Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations » 10:13 03/01/23 03/01 10:13 03/01/23 10:13 UHS Universal Health $128.35 / -5.21 (-3.90%) , PG Procter & Gamble $137.18 / -0.46 (-0.33%) , PM Philip Morris $97.93 / +0.57 (+0.59%) , MKSI MKS Instruments $96.97 / -0.035 (-0.04%) , SRPT Sarepta $151.32 / +29.13 (+23.84%) , GO Grocery Outlet $26.07 / -1.04 (-3.84%) , SPR Spirit AeroSystems $33.60 / -0.59 (-1.73%) , IHRT iHeartMedia $4.80 / -2.445 (-33.75%) , MQ Marqeta $4.51 / -1.3 (-22.38%) , JNJ Johnson & Johnson $152.70 / -0.49 (-0.32%) , RIVN Rivian Automotive $16.80 / -2.48 (-12.86%) , ABBV AbbVie $153.11 / -0.79 (-0.51%) , PLTR Palantir $7.77 / -0.07 (-0.89%) , ANIP ANI Pharmaceuticals $41.85 / +0.43 (+1.04%) , SPOT Spotify $117.56 / +1.24 (+1.07%) Want to get stock-moving… Open Full Text ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options UHS SRPT SPR SPOT RIVN PM PLTR PG MQ MKSI JNJ IHRT GO ANIP ABBV UHS Universal Health $128.35 / -5.21 (-3.90%) 02/28/23 Universal Health falls -10.5% SRPT Sarepta $151.32 / +29.13 (+23.84%) 02/17/23 Sarepta announces first patient dosed in SRP-9003-102 study 02/13/23 Soros Fund buys Horizon Therapeutics, exits BNY Mellon in Q4 01/05/23 Catalent, Sarepta expand commercial collaboration with deal for DMD candidate 11/28/22 Sarepta announces FDA grants priority review for SRP-9001 BLA SPR Spirit AeroSystems $33.60 / -0.59 (-1.73%) 03/01/23 Spirit AeroSystems enters MRO agreement with Joramco 11/07/22 Spirit AeroSystems rises 13.1% 10/19/22 Spirit AeroSystems enters MOU with Joramco for MRO services cooperation 09/21/22 Spirit AeroSystems enters MOU with MAB to develop MRO services for 737 aircraft SPOT Spotify $117.56 / +1.24 (+1.07%) 01/31/23 Spotify rises 9.8% 01/31/23 Spotify reports Q4 MAUs up 20% y/y to 489M 01/26/23 Spotify tweets 'everything's looking much better now' 01/26/23 Spotify says 'something's not quite right,' company investigating RIVN Rivian Automotive $16.80 / -2.48 (-12.86%) 02/28/23 Rivian Automotive down 6% following quarterly report 02/28/23 Rivian Automotive sees 50,000 vehicles produced in 2023 02/14/23 Greenlight buys Tenet, exits Intel in Q4 PM Philip Morris $97.93 / +0.57 (+0.59%) 01/29/23 Philip Morris announces agreement to extend, deepen collaboration with KT&G 01/26/23 FDA authorizes three new Marlboro heated tobacco products 01/22/23 Fly Intel: Top five weekend stock stories 01/08/23 Fly Intel: Top five weekend stock stories PLTR Palantir $7.77 / -0.07 (-0.89%) 02/14/23 Palantir rises 12.7% 02/14/23 Palantir rises 10.8% 02/14/23 Palantir rises 9.6% 02/13/23 Palantir jumps 18% to $8.99 after reporting profitable quarter PG Procter & Gamble $137.18 / -0.46 (-0.33%) 02/14/23 Nelson Peltz's Trian buys Disney, cuts Sysco in Q4 01/19/23 Procter & Gamble says 'on track' to deliver FY23 guidance 01/19/23 Procter & Gamble says Q2 growth broad based across business units 01/19/23 Procter & Gamble reports Q2 gross margin down 160 bps vs. a year ago MQ Marqeta $4.51 / -1.3 (-22.38%) 02/23/23 Marqeta appoints Crystal Sumner as Chief Legal Officer 01/30/23 Marqeta acquires Power Finance for $223M cash plus $52M milestone 01/26/23 Marqeta names Simon Khalaf as CEO 12/07/22 Marqeta integrates with Mastercard Track Instant Pay virtual card solution MKSI MKS Instruments $96.97 / -0.035 (-0.04%) 02/27/23 MKS Instruments sees ransomware incident having material impact on Q1 results 02/13/23 MKS Instruments reschedules Q4, 2022 earnings call due to ransomware event 12/14/22 MKS Instruments presents long-term strategy, financial outlook at Analyst Day 11/01/22 MKS Instruments appoints Chang as Senior Vice President, General Manager, Asia JNJ Johnson & Johnson $152.70 / -0.49 (-0.32%) 03/01/23 Cidara Therapeutics announces interim Phase 2a data of CD388 02/23/23 Zhongchao renews partnership with Johnson & Johnson China 02/14/23 Johnson & Johnson appoints Dr. John Reed as EVP of Pharmaceuticals, R&D 02/09/23 Roche expands collaboration with Janssen to create companion diagnostics IHRT iHeartMedia $4.80 / -2.445 (-33.75%) 12/14/22 Cerence enters partnerships with iHeartMedia, Radioline 11/28/22 California AG announces settlements against Google, iHeartMedia over radio ads 11/28/22 FTC, state AGs announce settlement with Google and iHeartMedia over Pixel 4 ads 09/23/22 iHeartMedia, Neustar announce new marketing partnership GO Grocery Outlet $26.07 / -1.04 (-3.84%) 11/09/22 Uber, Grocery Outlet expand partnership 11/08/22 Grocery Outlet announces CEO transition plan, Sheedy to become CEO ANIP ANI Pharmaceuticals $41.85 / +0.43 (+1.04%) 12/19/22 ANI Pharmaceuticals announces FDA approval of ANDA for Levocarnitine Tablets 11/28/22 ANI Pharmaceuticals receives FDA approval for ANDA for Fluoxetine Oral Solution 11/16/22 ANI Pharmaceuticals' Triimethoprim Tables USP approved by FDA 09/12/22 ANI Pharmaceuticals names Krista Davis as Chief Human Resources Officer ABBV AbbVie $153.11 / -0.79 (-0.51%) 02/27/23 AbbVie receives CHMP opinion recommending approval for upadacitinib 02/23/23 AbbVie, Capsida announce expanded genetic medicines for eye diseases pact 02/09/23 AbbVie says 'high level of confidence' in achieving FY23 guidance 02/09/23 AbbVie expects inflation to weigh on aesthetics business in 2023 UHS PG PM MKSI SRPT GO SPR IHRT MQ JNJ RIVN ABBV PLTR ANIP SPOT UHS Universal Health $128.35 / -5.21 (-3.90%) 03/01/23 RBC Capital Universal Health price target raised to $130 from $114 at RBC Capital 03/01/23 Stephens Universal Health price target lowered to $140 from $155 at Stephens 03/01/23 Wolfe Research Universal Health downgraded to Peer Perform at Wolfe after FY23 guidance 03/01/23 Wolfe Research Universal Health downgraded to Peer Perform from Outperform at Wolfe Research PG Procter & Gamble $137.18 / -0.46 (-0.33%) 03/01/23 UBS Procter & Gamble upgraded to Buy from Neutral at UBS 02/16/23 Citi Citi launches beverage, personal space with six buys, two sells 02/16/23 Citi Procter & Gamble initiated with a Buy at Citi 01/20/23 Stifel Procter & Gamble price target raised to $147 from $139 at Stifel PM Philip Morris $97.93 / +0.57 (+0.59%) 03/01/23 UBS UBS upgrades Philip Morris to Buy into heated tobacco launches 03/01/23 UBS Philip Morris upgraded to Buy from Neutral at UBS 02/02/23 Morgan Stanley Philip Morris price target raised to $118 from $109 at Morgan Stanley 01/25/23 Goldman Sachs Philip Morris upgraded to Buy from Neutral at Goldman Sachs MKSI MKS Instruments $96.97 / -0.035 (-0.04%) 03/01/23 Benchmark MKS Instruments upgraded to Buy at Benchmark ahead of cyclical upswing in 2024 03/01/23 Wells Fargo MKS Instruments price target raised to $95 from $90 at Wells Fargo 03/01/23 Benchmark MKS Instruments upgraded to Buy from Hold at Benchmark 01/30/23 Deutsche Bank MKS Instruments price target raised to $110 from $90 at Deutsche Bank SRPT Sarepta $151.32 / +29.13 (+23.84%) 03/01/23 RBC Capital Sarepta price target raised to $226 from $195 at RBC Capital 03/01/23 Oppenheimer Sarepta price target raised to $180 from $150 at Oppenheimer 03/01/23 Credit Suisse Sarepta price target raised to $144 from $137 at Credit Suisse 03/01/23 Needham Needham ups Sarepta target to $200, adds to Conviction list GO Grocery Outlet $26.07 / -1.04 (-3.84%) 03/01/23 Craig-Hallum Craig-Hallum downgrades Grocery Outlet to Hold, cuts price target to $29 03/01/23 Craig-Hallum Grocery Outlet downgraded to Hold from Buy at Craig-Hallum 12/19/22 Credit Suisse Grocery Outlet initiated with a Neutral at Credit Suisse 11/09/22 Deutsche Bank Grocery Outlet price target lowered to $41 from $43 at Deutsche Bank SPR Spirit AeroSystems $33.60 / -0.59 (-1.73%) 03/01/23 Bernstein Spirit AeroSystems downgraded to Market Perform from Outperform at Bernstein 02/13/23 Barclays Spirit AeroSystems price target raised to $50 from $42 at Barclays 02/09/23 Bernstein Spirit AeroSystems price target raised to $46 from $41 at Bernstein 02/08/23 Susquehanna Spirit AeroSystems price target raised to $44 from $40 at Susquehanna IHRT iHeartMedia $4.80 / -2.445 (-33.75%) 03/01/23 B. Riley iHeartMedia price target lowered to $16 from $22 at B. Riley 03/01/23 JPMorgan iHeartMedia downgraded to Underweight from Neutral at JPMorgan 02/28/23 Wells Fargo iHeartMedia price target lowered to $8 from $10 at Wells Fargo 01/17/23 B. Riley iHeartMedia price target lowered to $22 from $23 at B. Riley MQ Marqeta $4.51 / -1.3 (-22.38%) 03/01/23 DA Davidson Marqeta price target lowered to $5.00 from $7.25 at DA Davidson 03/01/23 Credit Suisse Marqeta price target lowered to $8 from $13.50 at Credit Suisse 03/01/23 JPMorgan Marqeta downgraded to Neutral from Overweight at JPMorgan 02/28/23 Morgan Stanley Marqeta price target lowered to $8 from $14 at Morgan Stanley JNJ Johnson & Johnson $152.70 / -0.49 (-0.32%) 03/01/23 Guggenheim Johnson & Johnson initiated with a Neutral, $161 price target at Guggenheim 02/28/23 Guggenheim Johnson & Johnson initiated with a Neutral at Guggenheim 02/07/23 RBC Capital Arrowhead price target lowered to $77 from $83 at RBC Capital 02/06/23 Piper Sandler Arrowhead price target lowered to $52 from $55 at Piper Sandler RIVN Rivian Automotive $16.80 / -2.48 (-12.86%) 03/01/23 RBC Capital Rivian Automotive price target lowered to $28 from $50 at RBC Capital 03/01/23 DA Davidson Rivian Automotive price target lowered to $16 from $23 at DA Davidson 03/01/23 Canaccord Rivian Automotive price target lowered to $40 from $55 at Canaccord 03/01/23 Wedbush Rivian Automotive price target lowered to $25 from $37 at Wedbush ABBV AbbVie $153.11 / -0.79 (-0.51%) 03/01/23 Guggenheim Guggenheim starts AbbVie with a Buy on diversified growth 02/28/23 Guggenheim AbbVie initiated with a Buy at Guggenheim 02/22/23 BMO Capital AbCellera price target lowered to $32 from $40 at BMO Capital 02/22/23 Wolfe Research AbbVie downgraded to Peer Perform on valuation at Wolfe Research PLTR Palantir $7.77 / -0.07 (-0.89%) 03/01/23 DA Davidson Palantir initiated with a Neutral at DA Davidson 02/28/23 DA Davidson Palantir initiated with a Neutral at DA Davidson 02/22/23 Deutsche Bank Palantir 2023 outlook 'certainly not without risk,' says Deutsche Bank 02/21/23 William Blair William Blair sees three of Palantir's four largest contracts as 'in play' ANIP ANI Pharmaceuticals $41.85 / +0.43 (+1.04%) 03/01/23 Guggenheim Guggenheim starts ANI Pharmaceuticals at Buy on cortrophin gel's potential 02/28/23 Guggenheim ANI Pharmaceuticals initiated with a Buy at Guggenheim 09/07/22 H.C. Wainwright ANI Pharmaceuticals initiated with a Buy at H.C. Wainwright 03/16/22 Raymond James ANI Pharmaceuticals price target lowered to $47 from $65 at Raymond James SPOT Spotify $117.56 / +1.24 (+1.07%) 03/01/23 Redburn Spotify upgraded to Buy from Neutral at Redburn 02/06/23 Wells Fargo Spotify upgraded to Overweight from Equal Weight at Wells Fargo 02/06/23 Atlantic Equities Spotify upgraded to Overweight from Neutral at Atlantic Equities 02/01/23 Truist Spotify price target raised to $132 from $115 at Truist UHS SRPT SPR SPOT RIVN PM PLTR PG MQ MKSI JNJ IHRT GO ANIP ABBV UHS Universal Health $128.35 / -5.21 (-3.90%) 02/27/23 Universal Health sees FY23 adjusted EPS of $9.50-$10.50, consensus $10.79 02/27/23 Universal Health reports Q4 adjusted EPS $3.02, consensus $2.96 02/27/23 Notable companies reporting after market close 10/25/22 Universal Health reports Q3 adjusted EPS $2.54, consensus $3.43 SRPT Sarepta $151.32 / +29.13 (+23.84%) 02/28/23 Sarepta reports Q4 EPS ($1.24), consensus ($1.35) 01/09/23 Sarepta expects to exceed FY22 guidance for net product revenues 11/02/22 Sarepta reports Q EPS (80c), consensus (1.43) SPR Spirit AeroSystems $33.60 / -0.59 (-1.73%) 02/07/23 Spirit AeroSystems reports Q4 adjusted EPS ($1.46), consensus (21c) 02/06/23 Notable companies reporting before tomorrow's open 11/03/22 Spirit AeroSystems reports Q3 EPS (15c), consensus (40c) SPOT Spotify $117.56 / +1.24 (+1.07%) 01/31/23 Spotify sees Q1 revenue EUR 3.1B, gross margin 24.9% 01/31/23 Spotify reports Q4 EPS (EUR 1.40) vs. (EUR 0.20) last year 10/25/22 Spotify reports Q3 Operating loss EUR (228M) vs. profit EUR 75M prior RIVN Rivian Automotive $16.80 / -2.48 (-12.86%) 02/28/23 Rivian Automotive reports Q4 adjusted EPS ($1.73), consensus ($1.94) 02/02/23 Amazon reports Q4 EPS 3c with Rivian loss, consensus 17c 11/09/22 Rivian Automotive reports Q3 adjusted EPS ($1.57), consensus ($1.82) PM Philip Morris $97.93 / +0.57 (+0.59%) 02/09/23 Philip Morris sees FY23 adjusted EPS, ex-currency $6.40-$6.52, consensus $5.90 02/09/23 Philip Morris sees FY23 currency-neutral adjusted EPS growth of 7%-9% 02/09/23 Philip Morris reports Q4 adjusted EPS ex-RU/UA $1.23, consensus $1.24 02/08/23 Notable companies reporting before tomorrow's open PLTR Palantir $7.77 / -0.07 (-0.89%) 02/13/23 Palantir sees FY23 revenue $2.18B-$2.23B, consensus $2.29B 02/13/23 Palantir sees Q1 revenue $503M-$507M, consensus $520M 02/13/23 Palantir reports Q4 adjusted EPS 4c, consensus 3c 02/13/23 Notable companies reporting after market close PG Procter & Gamble $137.18 / -0.46 (-0.33%) 01/19/23 Procter & Gamble raises FY23 sales growth outlook 01/19/23 Procter & Gamble reports Q2 core EPS $1.59, consensus $1.59 01/18/23 Notable companies reporting before tomorrow's open MQ Marqeta $4.51 / -1.3 (-22.38%) 02/28/23 Marqeta sees Q1 net revenue growth 26%-28%, consensus $214.08M 02/28/23 Marqeta reports Q4 EPS (5c), consensus (9c) 02/28/23 Notable companies reporting after market close 11/09/22 Marqeta sees Q4 revenue up 29%-31%, consensus $191M MKSI MKS Instruments $96.97 / -0.035 (-0.04%) 02/27/23 MKS Instruments sees Q1 revenue ex-ransomware impact $1B, consensus $928.16M 02/27/23 MKS Instruments reports Q4 EPS $2.00, consensus $1.34 02/27/23 MKS Instruments reports Q4 adjusted EPS $2.00, consensus $1.34 11/02/22 MKS Instruments sees Q4 EPS $1.34 +/- 27c, consensus $2.26 JNJ Johnson & Johnson $152.70 / -0.49 (-0.32%) 02/28/23 Fate Therapeutics reports Q4 EPS (58c), consensus (86c) 01/30/23 Johnson & Johnson to challenge federal appeals court ruling 01/24/23 Johnson & Johnson sees FY23 adjusted EPS $10.45- $10.65, consensus $10.33 01/24/23 Johnson & Johnson sees FY23 adjusted operational EPS $10.40-$10.60 IHRT iHeartMedia $4.80 / -2.445 (-33.75%) 02/28/23 iHeartMedia sees Q1 revenue down mid-single digits 02/28/23 iHeartMedia reports Q4 adjusted EBITDA $316M, up 7% from last year 11/03/22 iHeartMedia sees Q4 revenue growth 2%-6%, consensus $1.14B 11/03/22 iHeartMedia reports Q3 revenue $989M, consensus $975.44M GO Grocery Outlet $26.07 / -1.04 (-3.84%) 02/28/23 Grocery Outlet sees FY23 EPS 94c-99c, consensus $1.14 02/28/23 Grocery Outlet reports Q4 EPS 25c, consensus 23c 11/08/22 Grocery Outlet narrows FY22 adjusted EPS guidance to $1.00 from 97c-$1.00, 11/08/22 Grocery Outlet reports Q3 adjusted EPS 27c, consensus 26c ANIP ANI Pharmaceuticals $41.85 / +0.43 (+1.04%) 11/09/22 ANI Pharmaceuticals backs FY22 adjusted EPS view $1.34-$1.62, consensus $1.37 11/09/22 ANI Pharmaceuticals reports Q3 adjusted EPS 64c, consensus 55c ABBV AbbVie $153.11 / -0.79 (-0.51%) 02/09/23 AbbVie sees Q1 adjusted EPS $2.39-$2.49, consensus $3.08 02/09/23 AbbVie sees FY23 revenue about $52B, consensus $54.21B 02/09/23 AbbVie sees FY23 adjusted EPS $10.70-$11.10, consensus $11.65 02/09/23 AbbVie reports Q4 adjusted EPS $3.60, consensus $3.56 SPOT RIVN PM PLTR PG JNJ ABBV SPOT Spotify $117.56 / +1.24 (+1.07%) 02/28/23 EU narrows Apple probe to app restrictions, FT reports 02/10/23 ValueAct takes stake in Spotify, Bloomberg reports 12/13/22 Spotify steps back from live audio programming, Bloomberg says 10/26/22 Spotify to raise prices in U.S. in 2023, WSJ reports RIVN Rivian Automotive $16.80 / -2.48 (-12.86%) 02/03/23 Rivian Automotive to expand lineup with development of e-bike, Bloomberg says 02/03/23 Rivian CEO says working on electric bikes, Bloomberg reports 02/01/23 Rivian Automotive to reduce workforce by 6%, Reuters reports 02/01/23 Rivian Automotive cutting workforce by 6%, Reuters reports PM Philip Morris $97.93 / +0.57 (+0.59%) 01/25/23 Juul in deal discussions with Philip Morris, Altria, Japan Tobacco, WSJ says 01/21/23 Wells Fargo, Disney among stocks watched by value investors, Barron's says 01/07/23 Philip Morris' stock about to get 'smoking hot,' Barron's says 12/12/22 Supreme Court declines to halt California flavored tobacco ban, Bloomberg says PLTR Palantir $7.77 / -0.07 (-0.89%) 02/27/23 Palantir tells Bloomberg 2% of workforce to be cut PG Procter & Gamble $137.18 / -0.46 (-0.33%) 10/17/22 Procter & Gamble bets inflation won't push shoppers to swap brands, WSJ reports 10/10/22 Environmentalists to challenge P&G CEO as chairman, Reuters says JNJ Johnson & Johnson $152.70 / -0.49 (-0.32%) 02/01/23 Novavax refuses to refund $700M for COVID shots never delivered, NY Times says 01/30/23 Appeals court dismisses Chapter 11 case of J&J unit, WSJ reports 01/13/23 Johnson & Johnson cuts production of Covid-19 vaccine, WSJ reports 01/09/23 J&J may look for deals that boost eye care, surgical robots units, Reuters says ABBV AbbVie $153.11 / -0.79 (-0.51%) 02/06/23 AbbVie looking for next hit drug after competitors target Humira, WSJ reports 01/31/23 AbbVie's Humira drug faces competition in the U.S., FT reports 12/03/22 Buy AbbVie, stock still worth owning even as Humira fades, Barron's says 11/16/22 Optum Rx puts biosimilars on formulary against AbbVie's Humira, Bloomberg says UHS SRPT SPR SPOT RIVN PM PLTR PG MQ MKSI JNJ IHRT GO ABBV UHS Universal Health $128.35 / -5.21 (-3.90%) 02/27/23 Fly Intel: After-Hours Movers 01/24/23 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 10/25/22 Fly Intel: After-Hours Movers SRPT Sarepta $151.32 / +29.13 (+23.84%) 02/28/23 Fly Intel: After-Hours Movers 01/09/23 What You Missed On Wall Street On Monday 12/16/22 What You Missed On Wall Street On Friday 12/16/22 What You Missed On Wall Street This Morning SPR Spirit AeroSystems $33.60 / -0.59 (-1.73%) 02/07/23 Fly Intel: Pre-market Movers 11/11/22 What You Missed On Wall Street On Friday 11/11/22 What You Missed On Wall Street This Morning 11/11/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations SPOT Spotify $117.56 / +1.24 (+1.07%) 02/11/23 Buy/Sell: Wall Street's top 10 stock calls this week 02/10/23 What You Missed On Wall Street This Morning 02/06/23 What You Missed On Wall Street On Monday RIVN Rivian Automotive $16.80 / -2.48 (-12.86%) 02/27/23 What You Missed This Week in EVs and Clean Energy 02/22/23 Here's what Wall Street experts are saying about these EV names ahead of results PM Philip Morris $97.93 / +0.57 (+0.59%) 02/09/23 Fly Intel: Pre-market Movers 01/25/23 What You Missed On Wall Street On Wednesday 01/25/23 What You Missed On Wall Street This Morning 01/25/23 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations PLTR Palantir $7.77 / -0.07 (-0.89%) 02/14/23 What You Missed On Wall Street On Tuesday 02/14/23 What You Missed On Wall Street This Morning 02/14/23 Fly Intel: Pre-market Movers 02/13/23 Fly Intel: After-Hours Movers PG Procter & Gamble $137.18 / -0.46 (-0.33%) 01/19/23 What You Missed On Wall Street On Thursday 01/19/23 What You Missed On Wall Street This Morning 01/19/23 Fly Intel: Pre-market Movers 11/26/22 Buy/Sell: Wall Street's top 10 stock calls this week MQ Marqeta $4.51 / -1.3 (-22.38%) 03/01/23 Fly Intel: Pre-market Movers 11/11/22 Sell these stocks now, proven algorithm says 11/10/22 What You Missed On Wall Street On Thursday MKSI MKS Instruments $96.97 / -0.035 (-0.04%) 12/23/22 Buy/Sell: Wall Street's top 10 stock calls this week 12/20/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations JNJ Johnson & Johnson $152.70 / -0.49 (-0.32%) 01/30/23 What You Missed On Wall Street On Monday 01/30/23 What You Missed On Wall Street This Morning 01/24/23 What You Missed On Wall Street On Tuesday 01/24/23 What You Missed On Wall Street This Morning IHRT iHeartMedia $4.80 / -2.445 (-33.75%) 11/03/22 Fly Intel: After-Hours Movers GO Grocery Outlet $26.07 / -1.04 (-3.84%) 10/31/22 Fly Insider: Streamline Health, Deere among week's notable insider trades ABBV AbbVie $153.11 / -0.79 (-0.51%) 02/22/23 What You Missed On Wall Street On Wednesday 02/22/23 What You Missed On Wall Street This Morning 02/22/23 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 02/10/23 What You Missed On Wall Street On Friday 03/09/23 Biopharma/Biotech 03/17/23 2023 AAD Annual Meeting 03/09/23 ANI Pharmaceuticals - ANIP 04/20/23 Philip Morris - PM 04/21/23 Procter & Gamble - PG 05/21/23 PDUFA Date for Epcoritamab (DuoBody-CD3xCD20) 05/29/23 PDUFA Date for SRP-9001 UHS SPR SPOT RIVN PM PLTR PG MQ JNJ ABBV UHS Universal Health $128.35 / -5.21 (-3.90%) 10/26/22 Early notable gainers among liquid option names on October 26th 10/24/22 Early notable gainers among liquid option names on October 24th SPR Spirit AeroSystems $33.60 / -0.59 (-1.73%) 12/29/22 Largest borrow rate increases among liquid names SPOT Spotify $117.56 / +1.24 (+1.07%) 02/10/23 Spotify call volume above normal and directionally bullish 01/31/23 Unusually active option classes on open January 31st 01/23/23 Unusually active option classes on open January 23rd 01/19/23 Spotify call volume above normal and directionally bullish RIVN Rivian Automotive $16.80 / -2.48 (-12.86%) 02/28/23 Rivian options imply 11.8% move in share price post-earnings 02/02/23 Rivian call volume above normal and directionally bullish 01/31/23 Rivian call volume above normal and directionally bullish 01/27/23 Rivian call volume above normal and directionally bullish PM Philip Morris $97.93 / +0.57 (+0.59%) 02/24/23 Philip Morris call volume above normal and directionally bullish 01/19/23 Early notable gainers among liquid option names on January 19th 10/31/22 Philip Morris put volume heavy and directionally bearish 09/23/22 Philip Morris put volume heavy and directionally bearish PLTR Palantir $7.77 / -0.07 (-0.89%) 02/15/23 Unusually active option classes on open February 15th 02/13/23 Palantir Technologies call volume above normal and directionally bullish 02/08/23 Palantir Technologies call volume above normal and directionally bullish 02/06/23 Palantir Technologies call volume above normal and directionally bullish PG Procter & Gamble $137.18 / -0.46 (-0.33%) 01/25/23 Procter & Gamble call volume above normal and directionally bullish 01/19/23 Unusually active option classes on open January 19th 01/11/23 Largest borrow rate increases among liquid names 11/21/22 Unusually active option classes on open November 21st MQ Marqeta $4.51 / -1.3 (-22.38%) 11/09/22 Marqeta options imply 11.6% move in share price post-earnings JNJ Johnson & Johnson $152.70 / -0.49 (-0.32%) 01/31/23 Johnson & Johnson put buyer realizes 135% same-day gains 01/30/23 Johnson & Johnson put volume heavy and directionally bearish 01/24/23 Unusually active option classes on open January 24th 01/20/23 Johnson & Johnson put buyer realizes 33% same-day gains ABBV AbbVie $153.11 / -0.79 (-0.51%) 02/09/23 Unusually active option classes on open February 9th 01/18/23 Unusually active option classes on open January 18th 10/28/22 Unusually active option classes on open October 28th
Initiation	Guggenheim starts AbbVie with a Buy on diversified growth » 06:31 03/01/23 03/01 06:31 03/01/23 06:31 ABBV AbbVie $153.90 / -0.3801 (-0.25%) As previously reported,… As previously reported, Guggenheim analyst Vamil Divan initiated coverage of AbbVie with a Buy rating and $172 price target. Investors have "naturally" been focused on Humira's erosion curve as it loses U.S. market exclusivity, but the firm believes that has led to people overlooking the strength of the rest of AbbVie's business, including Skyrizi, Rinvoq, and Vraylar, each of which can drive further upside through recent or upcoming line extensions, the analyst tells investors. The firm also expects pipeline assets, such as epcoritamab and Teliso-V, to help stabilize the company's oncology franchise. ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options ABBV AbbVie $153.90 / -0.3801 (-0.25%) 02/27/23 AbbVie receives CHMP opinion recommending approval for upadacitinib 02/23/23 AbbVie, Capsida announce expanded genetic medicines for eye diseases pact 02/09/23 AbbVie says 'high level of confidence' in achieving FY23 guidance 02/09/23 AbbVie expects inflation to weigh on aesthetics business in 2023 ABBV AbbVie $153.90 / -0.3801 (-0.25%) 02/28/23 Guggenheim AbbVie initiated with a Buy at Guggenheim 02/22/23 BMO Capital AbCellera price target lowered to $32 from $40 at BMO Capital 02/22/23 Wolfe Research AbbVie downgraded to Peer Perform on valuation at Wolfe Research 02/22/23 Wolfe Research AbbVie downgraded to Peer Perform from Outperform at Wolfe Research ABBV AbbVie $153.90 / -0.3801 (-0.25%) 02/09/23 AbbVie sees Q1 adjusted EPS $2.39-$2.49, consensus $3.08 02/09/23 AbbVie sees FY23 revenue about $52B, consensus $54.21B 02/09/23 AbbVie sees FY23 adjusted EPS $10.70-$11.10, consensus $11.65 02/09/23 AbbVie reports Q4 adjusted EPS $3.60, consensus $3.56 ABBV AbbVie $153.90 / -0.3801 (-0.25%) 02/06/23 AbbVie looking for next hit drug after competitors target Humira, WSJ reports 01/31/23 AbbVie's Humira drug faces competition in the U.S., FT reports 12/03/22 Buy AbbVie, stock still worth owning even as Humira fades, Barron's says 11/16/22 Optum Rx puts biosimilars on formulary against AbbVie's Humira, Bloomberg says ABBV AbbVie $153.90 / -0.3801 (-0.25%) 02/22/23 What You Missed On Wall Street On Wednesday 02/22/23 What You Missed On Wall Street This Morning 02/22/23 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 02/10/23 What You Missed On Wall Street On Friday 05/21/23 PDUFA Date for Epcoritamab (DuoBody-CD3xCD20) ABBV AbbVie $153.90 / -0.3801 (-0.25%) 02/09/23 Unusually active option classes on open February 9th 01/18/23 Unusually active option classes on open January 18th 10/28/22 Unusually active option classes on open October 28th
Initiation	AbbVie initiated with a Buy at Guggenheim » 16:18 02/28/23 02/28 16:18 02/28/23 16:18 ABBV AbbVie $153.90 / -0.3801 (-0.25%) Guggenheim initiated… Guggenheim initiated coverage of AbbVie with a Buy rating and $172 price target. ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options ABBV AbbVie $153.90 / -0.3801 (-0.25%) 02/27/23 AbbVie receives CHMP opinion recommending approval for upadacitinib 02/23/23 AbbVie, Capsida announce expanded genetic medicines for eye diseases pact 02/09/23 AbbVie says 'high level of confidence' in achieving FY23 guidance 02/09/23 AbbVie expects inflation to weigh on aesthetics business in 2023 ABBV AbbVie $153.90 / -0.3801 (-0.25%) 02/22/23 BMO Capital AbCellera price target lowered to $32 from $40 at BMO Capital 02/22/23 Wolfe Research AbbVie downgraded to Peer Perform on valuation at Wolfe Research 02/22/23 Wolfe Research AbbVie downgraded to Peer Perform from Outperform at Wolfe Research 02/17/23 Alliance Global Partners CollPlant initiated with a Buy at Alliance Global Partners ABBV AbbVie $153.90 / -0.3801 (-0.25%) 02/09/23 AbbVie sees Q1 adjusted EPS $2.39-$2.49, consensus $3.08 02/09/23 AbbVie sees FY23 revenue about $52B, consensus $54.21B 02/09/23 AbbVie sees FY23 adjusted EPS $10.70-$11.10, consensus $11.65 02/09/23 AbbVie reports Q4 adjusted EPS $3.60, consensus $3.56 ABBV AbbVie $153.90 / -0.3801 (-0.25%) 02/06/23 AbbVie looking for next hit drug after competitors target Humira, WSJ reports 01/31/23 AbbVie's Humira drug faces competition in the U.S., FT reports 12/03/22 Buy AbbVie, stock still worth owning even as Humira fades, Barron's says 11/16/22 Optum Rx puts biosimilars on formulary against AbbVie's Humira, Bloomberg says ABBV AbbVie $153.90 / -0.3801 (-0.25%) 02/22/23 What You Missed On Wall Street On Wednesday 02/22/23 What You Missed On Wall Street This Morning 02/22/23 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 02/10/23 What You Missed On Wall Street On Friday 05/21/23 PDUFA Date for Epcoritamab (DuoBody-CD3xCD20) ABBV AbbVie $153.90 / -0.3801 (-0.25%) 02/09/23 Unusually active option classes on open February 9th 01/18/23 Unusually active option classes on open January 18th 10/28/22 Unusually active option classes on open October 28th

Get Full Fly Access

Breaking market intelligence sent straight to you: Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.

Up-to-date information on important industry events: Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.

News focused on the companies in your portfolio: Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.

14 Day Free Trial